Annual Publication Report 2010

Size: px
Start display at page:

Download "Annual Publication Report 2010"

Transcription

1 Annual Publication Report 2010 TABLE OF CONTENTS 2 GRONINGEN INSTITUTE FOR KIDNEY DISEASES GIKD 8 CARDIOVASCULAR CENTER CVC 18 GRONINGEN RESEARCH INSTITUTE FOR ASTHMA AND COPD GRIAC 24 CENTER FOR LIVER, DIGESTIVE AND METABOLIC DISEASES CLDS 33 INSTITUTE FOR TRANSPLANTATION, IMMUNITY AND INFLAMMATION TRIO 46 NORTHERN NETHERLANDS ONCOLOGY CENTER NNOC 63 INSTITUTE FOR BIOPHARMACEUTICALS: DISCOVERY, DESIGN AND DELIVERY BDDD 68 CENTER FOR SYNTHESIS AND ANALYSIS S&A

2 GRONINGEN INSTITUTE FOR KIDNEY DISEASES - GIKD Dissertations Gross, S. Advanced glycation and inflammatory phenomena in renal transplantion. (2010) Gans, R. O. B., Bierhaus, A. I., and Bakker, S. J. L. Halbesma, N. Predictors of accelerated renal function decline in the general population. (2010) de Jong, P. E., Stolk, R. P., and Gansevoort, R. T. Krikken, J. A. Metabolic aspects of dietary sodium restriction as a therapeutic intervention. (2010) Navis, G. J., Dullaert, R. P. F., and Bakker, S. J. L. Mahmoodi, B. K. Thromboembolic disease of the venous and the arterial system : two different entities or two different sides of the same coin? (2010) Kluin-Nelemans, J. C., Navis, G. J., and Gansevoort, R. T. Rienstra, H. Chronic tissue remodeling in renal transplantation : studies on cell origin, proteoglycans, and response to intervention. (2010) Hillebrands, J. L., Navis, G. J., van Goor, H., and van den Born, J. Schilte, M. N. Anti-inflammatory therapy and biomarker analysis inperitoneal dialysis. (2010) van den Born, J. Voorham, J. Assessing cardiometabolic treatment quality in general practice. (2010) Haaijer-Ruskamp, F. M., Wolffenbuttel, B. H. R., and Denig, P. Journal articles Abbasi, A., Corpeleijn, E., Postmus, D., Gansevoort, R. T., de Jong, P. E., Gans, R. O. B., Struck, J., Hillege, H. L., Stolk, R. P., Navis, G., Bakker, S. J. L. Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic Syndrome. Journal of Clinical Endocrinology & Metabolism 95(9): E26-E31, Alkhalaf, A., Bakker, S. J. L., Bilo, H. J. G., Gans, R. O. B., Navis, G. J., Postmus, D., Forsblom, C., Groop, P. H., Vionnet, N., Hadjadj, S., Marre, M., Parving, H. H., Rossing, P., Tarnow, L. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus. Diabetologia 53(12): , Alkhalaf, A., Zurbig, P., Bakker, S. J. L., Bilo, H. J. G., Cerna, M., Fischer, C., Fuchs, S., Janssen, B., Medek, K., Mischak, H., Roob, J. M., Rossing, K., Rossing, P., Rychlik, I., Sourij, H., Tiran, B., Winklhofer-Roob, B. M., Navis, G. J. Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy. PLoS ONE 5(10 AR e13421 DI /journal.pone ) Alkhalaf, A., Klooster, A., van Oeveren, W., Achenbach, U., Kleefstra, N., Slingerland, R. J., Mijnhout, G. S., Bilo, H. J. G., Gans, R. O. B., Navis, G. J., Bakker, S. J. L. A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy. Diabetes Care 33(7): , Altorf-van Der Kuil, W., Engberink, M. F., Brink, E. J., van Baak, M. A., Bakker, S. J. L., Navis, G., van't Veer, P., Geleijnse, J. M. Dietary Protein and Blood Pressure: A Systematic Review. PLoS ONE 5(8 AR e12102 DI /journal.pone ) Antoniou, AC Antoniou Antonis C. 1, Wang, XS Wang Xianshu 2, Fredericksen, ZS Fredericksen Zachary S. 3, McGuffog, L McGuffog Lesley 1, Tarrell, R Tarrell Robert 3, Sinilnikova, OM Sinilnikova Olga M. 4 5, Healey, S Healey Sue 6, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics 42(10): 885, 75 VARICK ST, 9TH FLR, NEW YORK, NY USA, NATURE PUBLISHING GROUP. Arsov, S., Graaff, R., Morariu, A. M., van Oeveren, W., Smit, A. J., Busletic, I., Trajcevska, L., Selim, G., Dzekova, P., Stegmayr, B., Sikole, A., Rakhorst, G. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients? Nephrology Dialysis Transplantation 25(3): , Baigent, C., Landray, M., Reith, C., Dasgupta, T., Emberson, J., Herrington, W., Lewis, D., Mafham, M., Collins, R., Collins, R., Baigent, C., Landray, M., Bray, C., Chen, Y., Baxter, A., Young, A., Hill, M., Knott, C., Cass, A., Feldt-Rasmussen, B., Fellstrom, B., Grobbee, R., Gronhagen-Riska, C., Haas, M., Holdaas, H., Hooi, L. S., Jiang, L., Kasiske, B., Krairittichai, U., Levin, A., Massy, Z., Tesar, V., Walker, R., Wanner, C., Wheeler, D., Wiecek, A., Dasgupta, T., Lewis, D., Mafham, M., Majoni, W., Reith, C., Simpson, D., Strony, J., Musliner, T., Agodoa, L., Armitage, J., Chen, Z., Craig, J., de Zeeuw, D., Gaziano, M., Grimm, R., Krane, V., Neal, B., Ophascharoensuk, V., Pedersen, T., Sleight, P., Tobert, J., Tomson, C., Sandercock, P., Hill, C., Keech, A., Whelton, P., Yusuf, S., Peto, R., Emberson, J., Parish, S. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering lowdensity lipoprotein cholesterol among 9,438 patients with 2

3 chronic kidney disease. American Heart Journal 160(5): 785- U28, Boersma, C., Gansevoort, R. T., Pechlivanoglou, P., Visser, S. T., van Toly, F. F. J., de Jong-van den Berg, de Jong, P. E., Postma, M. J. Screen-and-Treat Strategies for Albuminuria to Prevent Cardiovascular and Renal Disease: Cost-Effectiveness of Nationwide and Targeted Interventions Based on Analysis of Cohort Data From the Netherlands. Clinical Therapeutics 32(6): , Bouma, H. R., Ketelaar, M. E., Yard, B. A., Ploeg, R. J., Henning, R. H. Authors' Reply: AMP-Activated Protein Kinase as a Target for Preconditioning in Transplantation Medicine. Transplantation 90(11): 1242, Bouma, H. R., Strijkstra, A. M., Boerema, A. S., Deelman, L. E., Epema, A. H., Hut, R. A., Kroese, F. G. M., Henning, R. H. Blood cell dynamics during hibernation in the European Ground Squirrel. Veterinary Immunology and Immunopathology 136(3-4): , Bouma, H. R., Ketelaar, M. E., Yard, B. A., Ploeg, R. J., Henning, R. H. AMP-Activated Protein Kinase as a Target for Preconditioning in Transplantation Medicine. Transplantation 90(4): , Chambers, J. C., Zhang, W. H., Lord, G. M., van der Harst, P., Lawlor, D. A., Sehmi, J. S., Gale, D. P., Wass, M. N., Ahmadi, K. R., Bakker, S. J. L., Beckmann, J., Bilo, H. J. G., Bochud, M., Brown, M. J., Caulfield, M. J., Connell, J. M. C., Cook, H. T., Cotlarciuc, I., Smith, G. D., de Silva, R., Deng, G. H., Devuyst, O., Dikkeschei, L. D., Dimkovic, N., Dockrell, M., Dominiczak, A., Ebrahim, S., Eggermann, T., Farrall, M., Ferrucci, L., Floege, J., Forouhi, N. G., Gansevoort, R. T., Han, X. J., Hedblad, B., van der Heide, J. J. H., Hepkema, B. G., Hernandez-Fuentes, M., Hypponen, E., Johnson, T., de Jong, P. E., Kleefstra, N., Lagou, V., Lapsley, M., Li, Y., Loos, R. J. F., Luan, J., Luttropp, K., Marechal, C., Melander, O., Munroe, P. B., Nordfors, L., Parsa, A., Peltonen, L., Penninx, B. W., Perucha, E., Pouta, A., Prokopenko, I., Roderick, P. J., Ruokonen, A., Samani, N. J., Sanna, S., Schalling, M., Schlessinger, D., Schlieper, G., Seelen, M. A. J., Shuldiner, A. R., Sjogren, M., Smit, J. H., Snieder, H., Soranzo, N., Spector, T. D., Stenvinkel, P., Sternberg, M. J. E., Swaminathan, R., Tanaka, T., Ubink-Veltmaat, L. J., Uda, M., Vollenweider, P., Wallace, C., Waterworth, D., Zerres, K., Waeber, G., Wareham, N. J., Maxwell, P. H., McCarthy, M. I., Jarvelin, M. R., Mooser, V., Abecasis, G. R., Lightstone, L., Scott, J., Navis, G., Elliott, P., Kooner, J. S. Genetic loci influencing kidney function and chronic kidney disease. Nature Genetics 42(5): , Dallinga-Thie, G. M., Dullaart, R. P. F. Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations? Atherosclerosis 208(2): , Damman, K., Voors, A. A., Hillege, H. L., Navis, G., Lechat, P., van Veldhuisen, D. J., Dargie, H. J. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. European Journal of Heart Failure 12(9): , Damman, K., van Veldhuisen, D. J., Navis, G., Vaidya, V. S., Smilde, T. D. J., Westenbrink, B. D., Bonventre, J. V., Voors, A. A., Hillege, H. L. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96(16): , de Borst, M. H., Navis, G. Dietary Salt Reductions and Cardiovascular Disease. New England Journal of Medicine 362(23): , de Jong, P. E., Gansevoort, R. T. Albuminuria in non-primary renal disease: risk marker rather than risk factor. Nephrology Dialysis Transplantation 25(3): , de Leeuw, K., van der Graaf, A. M., Bijzet, J., Stegeman, C. A., Smit, A. J., Kallenberg, C. G., Bijl, M. Patients with Wegener's granulomatosis: a long-term follow-up study. Clinical and Experimental Rheumatology 28(1): S18-S23, de Leeuw, K., Nienhuis, H., Smit, A., Stegeman, C., Kallenberg, C., Bijl, M. Increased accumulation of advanced glycation endproducts in patients with Wegener's granulomatosis. Annals of the Rheumatic Diseases 69(3): , de Zeeuw, D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H. H., Pritchett, Y., Remuzzi, G., Ritz, E., Andress, D. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376(9752): , Dullaart, R. P. F., Horst-Schrivers, A. N. A., Koopmans, K. P. New imaging approaches to phaeochromocytomas and paragangliomas. Clinical Endocrinology 72(4): , Faas, M. M., van der Schaaf, G., Borghuis, T., Jongman, R. M., van Pampus, M. G., de Vos, P., van Goor, H., Bakker, W. W. Extracellular ATP induces albuminuria in pregnant rats. Nephrology Dialysis Transplantation 25(8): , Gansevoort, R. T., Nauta, F. L., Bakker, S. J. L. Albuminuria: all you need to predict outcomes in chronic kidney disease? Current Opinion in Nephrology and Hypertension 19(6): , Gansevoort, R. T., de Jong, P. E. Challenges for the present CKD classification system. Current Opinion in Nephrology and Hypertension 19(3): , Gross, S., van der Heide, J. J. H., van Son, W. J., Gans, R. O. B., Foell, D., Navis, G., Bakker, S. J. L. Body Mass Index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients. Medical Science Monitor 16(7): CR318-CR324, 3

4 Halbesma, N., Jansen, D. F., Stolk, R. P., de Jong, P. E., Gansevoort, R. T. Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study. Nephrology Dialysis Transplantation 25(6): , Heerspink, H. J. L., Gansevoort, R. T., Brenner, B. M., Cooper, M. E., Parving, H. H., Shahinfar, S., de Zeeuw, D. Comparison of Different Measures of Urinary Protein Excretion for Prediction of Renal Events. Journal of the American Society of Nephrology 21(8): , Heerspink, H. J. L., de Zeeuw, D. Dual RAS Therapy Not on Target, but Fully Alive. Nephron Clinical Practice 116(2): C137-C142, Heerspink, H. J. L., de Zeeuw, D. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial? American Journal of Nephrology 31(5): , Heerspink, H. L., de Zeeuw, D. Composite renal endpoints: was ACCOMPLISH accomplished? Lancet 375(9721): , Hellemons, M. E., Bakker, S. J. L. Vitamin D as an accelerator of atherosclerotic calcification: a D-tail that may be a Trojan horse. Diabetologia 53(12): 2688, Ikram, M. K., Xueling, S., Jensen, R. A., Cotch, M. F., Hewitt, A. W., Ikram, M. A., Wang, J. J., Klein, R., Klein, B. E. K., Breteler, M. M. B., Cheung, N., Liew, G., Mitchell, P., Uitterlinden, A. G., Rivadeneira, F., Hofman, A., de Jong, P. T. V. M., van Duijn, C. M., Kao, L., Cheng, C. Y., Smith, A. V., Glazer, N. L., Lumley, T., McKnight, B., Psaty, B. M., Jonasson, F., Eiriksdottir, G., Aspelund, T., Harris, T. B., Launer, L. J., Taylor, K. D., Li, X. H., Iyengar, S. K., Xi, Q. S., Sivakumaran, T. A., Mackey, D. A., MacGregor, S., Martin, N. G., Young, T. L., Bis, J. C., Wiggins, K. L., Heckbert, S. R., Hammond, C. J., Andrew, T., Fahy, S., Attia, J., Holliday, E. G., Scott, R. J., Islam, F. M. A., Rotter, J. I., McAuley, A. K., Boerwinkle, E., Tai, E. S., Gudnason, V., Siscovick, D. S., Vingerling, J. R., Wong, T. Y. Four Novel Loci (19q13, 6q24, 12q24, and 5q14) Influence the Microcirculation In Vivo. PLoS Genetics 6(10) Jun, M., Heerspink, H. J. L., Ninomiya, T., Gallagher, M., Bellomo, R., Myburgh, J., Finfer, S., Palevsky, P. M., Kellum, J. A., Perkovic, V., Cass, A. Intensities of Renal Replacement Therapy in Acute Kidney Injury: A Systematic Review and Meta-Analysis. Clinical Journal of the American Society of Nephrology 5(6): , Kamilic, J., Hamming, I., Kreutz, R., Bolbrinker, J., Siems, W. E., Nassar, I., Sluimer, J. C., Walther, T., Navis, G. J., van Goor, H. Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27. Hypertension Research 33(2): , Kok, R. J., Henning, R. H. Drug targeting to the kidney Preface. Advanced Drug Delivery Reviews 62(14): , Krikken, J. A., Gansevoort, R. T., Dullaart, R. P. F. Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. Journal of Lipid Research 51(7): , Krikken, J. A., van Ree, R. M., Klooster, A., Seelen, M. A., Borghuis, T., Lems, S. P. M., Schouten, J. P., Bakker, W. W., Gans, R. O. B., Navis, G., Bakker, S. J. L. High plasma hemopexin activity is an independent risk factor for late graft failure in renal transplant recipients. Transplant International 23(8): , Lely, A. T., Heerspink, H. J. L., Zuurman, M., Visser, F. W., Kocks, M. J. A., Boomsma, F., Navis, G. Response to angiotensin-converting enzyme inhibition is selectively blunted by high sodium in angiotensin-converting enzyme DD genotype: evidence for geneenvironment interaction in healthy volunteers. Journal of Hypertension 28(12): , Linssen, G. C. M., Bakker, S. J. L., Voors, A. A., Gansevoort, R. T., Hillege, H. L., de Jong, P. E., van Veldhuisen, D. J., Gans, R. O. B., de Zeeuw, D. N-terminal pro-b-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. European Heart Journal 31(1): , Linssen, G. C. M., Damman, K., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., Navis, G. Letter by van Kimmenade et al Regarding Article, "Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure" Response. Circulation 121(10): E243, Loureiro, J., Schilte, M., Aguilera, A., bar-vizcaino, P., Ramirez- Huesca, M., Perez-Lozano, M. L., Gonzalez-Mateo, G., Aroeira, L. S., Selgas, R., Mendoza, L., Ortiz, A., Ruiz-Ortega, M., van den Born, J., Beelen, R. H. J., Lopez-Cabrera, M. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrology Dialysis Transplantation 25(4): , Maahs, D. M., Siwy, J., Argiles, A., Cerna, M., Delles, C., Dominiczak, A. F., Gayrard, N., Iphofer, A., Jansch, L., Jerums, G., Medek, K., Mischak, H., Navis, G. J., Roob, J. M., Rossing, K., Rossing, P., Rychlik, I., Schiffer, E., Schmieder, R. E., Wascher, T. C., Winklhofer-Roob, B. M., Zimmerli, L. U., Zurbig, P., Snell- Bergeon, J. K. Urinary Collagen Fragments Are Significantly Altered in Diabetes: A Link to Pathophysiology. PLoS ONE 5(9 AR e13051 DI /journal.pone ) Martens, H. A., Gross, S., van der Steege, G., Brouwer, E., Berden, J. H. M., de Sevaux, R., Derksen, R. H. W. M., Voskuyl, A. E., Berger, S. P., Navis, G. J., Kallenberg, C. G. M., Bijl, M. Lack of Association of C-C Chemokine Receptor 5 Delta 32 Deletion Status with Rheumatoid Arthritis, Systemic Lupus Erythematosus, Lupus Nephritis, and Disease Severity. Journal of Rheumatology 37(11): , Martirosya, L., Voorham, J., Haaijer-Ruskamp, F. M., Braspenning, J., Wolffenbuttel, B. H. R., Denig, P. A systematic literature review: 4

5 prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management. Pharmacoepidemiology and Drug Safety 19(4): , Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., Coresh, J., Gansevoort, R. T. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375(9731): , Meijer, E., Rook, M., Tent, H., Navis, G., van der Jagt, E. J., de Jong, P. E., Gansevoort, R. T. Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology 5(6): , Meijer, E., de Jong, P. E., Gansevoort, R. T. Vasopressin and microalbuminuria: is it vasopressin per se or is it salt intake? Kidney International 77(9): , Meijer, E., Boertien, W. E., Nauta, F. L., Bakker, S. J. L., van Oeveren, W., Rook, M., van der Jagt, E. J., van Goor, H., Peters, D. J. M., Navis, G., de Jong, P. E., Gansevoort, R. T. Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal Dominant Polycystic Kidney Disease: A Crosssectional Analysis. American Journal of Kidney Diseases 56(5): , Meijer, E., Bakker, S. J. L., Halbesma, N., de Jong, P. E., Struck, J., Gansevoort, R. T. Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney International 77(1): 29-36, Mooyaart, A. L., Zutinic, A., Bakker, S. J. L., Grootendorst, D. C., Kleefstra, N., van Valkengoed, I. G. M., Bohringer, S., Bilo, H. J. G., Dekker, F. W., Bruijn, J. A., Navis, G., Janssen, B., Baelde, H. J., de Heer, E. Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific. Diabetes 59(6): , Mulder, G. M., Nijboer, W. N., Seelen, M. A., Sandovici, M., Bos, E. M., Melenhorst, W. B. W. H., Trzpis, M., Kloosterhuis, N. J., Visser, L., Henning, R. H., Leuvenink, H. G. D., Ploeg, R. J., Sunnarborg, S. W., van Goori, H. Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury. Journal of Pathology 221(2): , Navis, G., Bakker, S. J. L., van der Harst, P. Dissecting the genetics of complex traits: lessons from hypertension(*). Nephrology Dialysis Transplantation 25(5): , Nienhuis, H. L. A., de Leeuw, K., Bijzet, J., van Doormaal, J. J., van Roon, A. M., Smit, A. J., Graaff, R., Kallenberg, C. G. M., Bijl, M. Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness. Arthritis Research & Therapy 12(5 AR R181 DI /ar3145) Nijboer, W. N., Ottens, P. J., van Dijk, A., van Goor, H., Ploeg, R. J., Leuvenink, H. G. D. Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal function. Critical Care Medicine 38(4): , Noordzij, M. J., Lefrandt, J. D., Graaff, R., Smit, A. J. Skin Autofluorescence and Glycemic Variability. Diabetes Technology & Therapeutics 12(7): , Ocak, G., Verduijn, M., Vossen, C. Y., Lijfering, W. M., Dekker, F. W., Rosendaal, F. R., Gansevoort, R. T., Mahmoodi, B. K. Chronic kidney disease stages 1-3 increase the risk of venous thrombosis 30. Journal of Thrombosis and Haemostasis 8(11): , Ochodnicky, P., Henning, R. H., Buikema, H. J., de Zeeuw, D., Provoost, A. P., van Dokkum, R. P. E. Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat. American Journal of Physiology-Renal Physiology 298(3): F625-F633, Odden, M. C., Tager, I. B., Gansevoort, R. T., Bakker, S. J. L., Katz, R., Fried, L. F., Newman, A. B., Canada, R. B., Harris, T., Sarnak, M. J., Siscovick, D., Shlipak, M. G. Age and cystatin C in healthy adults: a collaborative study. Nephrology Dialysis Transplantation 25(2): , Ozyilmaz, A., Bakker, S. J. L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T. Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors. Nephrology Dialysis Transplantation 25(11): , Padmanabhan, S., Melander, O., Johnson, T., Di Blasio, A. M., Lee, W. K., Gentilini, D., Hastie, C. E., Menni, C., Monti, M. C., Delles, C., Laing, S., Corso, B., Navis, G., Kwakernaak, A. J., van der Harst, P., Bochud, M., Maillard, M., Burnier, M., Hedner, T., Kjeldsen, S., Wahlstrand, B., Sjogren, M., Fava, C., Montagnana, M., Danese, E., Torffvit, O., Hedblad, B., Snieder, H., Connell, J. M. C., Brown, M., Samani, N. J., Farrall, M., Cesana, G., Mancia, G., Signorini, S., Grassi, G., Eyheramendy, S., Wichmann, H. E., Laan, M., Strachan, D. P., Sever, P., Shields, D. C., Stanton, A., Vollenweider, P., Teumer, A., Volzke, H., Rettig, R., Newton-Cheh, C., Arora, P., Zhang, F., Soranzo, N., Spector, T. D., Lucas, G., Kathiresan, S., Siscovick, D. S., Luan, J. A., Loos, R. J. F., Wareham, N. J., Penninx, B. W., Nolte, I. M., McBride, M., Miller, W. H., Nicklin, S. A., Baker, A. H., Graham, D., McDonald, R. A., Pell, J. P., Sattar, N., Welsh, P., Munroe, P., Caulfield, M. J., Zanchetti, A., Dominiczak, A. F. Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension. PLoS Genetics 6(10 AR e DI /journal.pgen ) Riedl, E., Koeppel, H., Pfister, F., Peters, V., Sauerhoefer, S., Sternik, P., Brinkkoetter, P., Zentgraf, H., Navis, G., Henning, R. H., van den Born, J., Bakker, S. J. L., Janssen, B., van der Woude, F. J., Yard, B. A. N-Glycosylation of Carnosinase Influences Protein Secretion and 5

6 Enzyme Activity Implications for Hyperglycemia. Diabetes 59(8): , Rienstra, H., Katta, K., Celie, J. W. A. M., van Goor, H., Navis, G., van den Born, J., Hillebrands, J. L. Differential Expression of Proteoglycans in Tissue Remodeling and Lymphangiogenesis after Experimental Renal Transplantation in Rats. PLoS ONE 5(2 AR e9095 DI /journal.pone ): e9095, Sandovici, M., Deelman, L. E., Benigni, A., Henning, R. H. Towards graft-specific immune suppression: Gene therapy of the transplanted kidney. Advanced Drug Delivery Reviews 62(14): , Sarwar, N., Gao, P., Seshasai, S. R. K., Gobin, R., Kaptoge, S., Di Angelantonio, E., Ingelsson, E., Lawlor, D. A., Selvin, E., Stampfer, M., Stehouwer, C. D. A., Lewington, S., Pennells, L., Thompson, A., Sattar, N., White, I. R., Ray, K. K., Danesh, J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375(9733): , Schilte, M. N., Fabbrini, P., ter Wee, P. M., Keuning, E. D., Zareie, M., Tangelder, G. J., Van Lambalgen, A. A., Beelen, R. H. J., van den Born, J. Peritoneal Dialysis Fluid Bioincompatibility and New Vessel Formation Promote Leukocyte-Endothelium Interactions in a Chronic Rat Model for Peritoneal Dialysis. Microcirculation 17(4): , Slagman, M. C. J., Sinkeler, S. J., Hemmelder, M. H., Waanders, F., Vogt, L., Kluin-Nelemans, H. C., Navis, G., Laverman, G. D. Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function. Nephrology Dialysis Transplantation 25(10): , Slagman, M. C. J., Navis, G., Laverman, G. D. Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease. Current Opinion in Nephrology and Hypertension 19(2): , Slagman, M. C. J., Navis, G., Laverman, G. D. Reversible Effects of Diuretics Added to Renin-Angiotensin-Aldosterone System Blockade: Impact on Interpretation of Long-term Kidney Function Outcome. American Journal of Kidney Diseases 56(3): , Slagman, M. C. J., Sinkeler, S. J., Hemmelder, M. H., Waanders, F., Vogt, L., Kluin-Nelemans, H. C., Navis, G., Laverman, G. D. RAAS blockade in combination with diuretic therapy increases urine excretion, which in turn increases drinking and thus reduces erythropoietin and proteinuria - Reply. Nephrology Dialysis Transplantation 25(7): 2384, Smit, A. J., Gerrits, E. G. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease. Current Opinion in Nephrology and Hypertension 19(6): , Sofat, R., Hingorani, A. D., Smeeth, L., Humphries, S. E., Talmud, P. J., Cooper, J., Shah, T., Sandhu, M. S., Ricketts, S. L., Boekholdt, S. M., Wareham, N., Khaw, K. T., Kumari, M., Kivimaki, M., Marmot, M., Asselbergs, F. W., van der Harst, P., Dullaart, R. P. F., Navis, G., van Veldhuisen, D. J., van Gilst, W. H., Thompson, J. F., McCaskie, P., Palmer, L. J., Arca, M., Quagliarini, F., Gaudio, C., Cambien, F., Nicaud, V., Poirer, O., Gudnason, V., Isaacs, A., Witteman, J. C. M., van Duijn, C. M., Pencina, M., Vasan, R. S., D'Agostino, R. B., Ordovas, J., Li, T. Y., Kakko, S., Kauma, H., Savolainen, M. J., Kesaniemi, Y. A., Sandhofer, A., Paulweber, B., Sorli, J. V., Goto, A., Yokoyama, S., Okumura, K., Horne, B. D., Packard, C., Freeman, D., Ford, I., Sattar, N., McCormack, V., Lawlor, D. A., Ebrahim, S., Smith, G. D., Kastelein, J. J. P., Deanfield, J., Casas, J. P. Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms. Circulation 121(1): 52-62, Solomon, S. D., Uno, H., Lewis, E. F., Eckardt, K. U., Lin, J., Burdmann, E. A., de Zeeuw, D., Ivanovich, P., Levey, A. S., Parfrey, P., Remuzzi, G., Singh, A. K., Toto, R., Huang, F., Rossert, J., McMurray, J. J. V., Pfeffer, M. A. Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes. New England Journal of Medicine 363(12): , Sotoodehnia, N., Isaacs, A., de Bakker, P. I. W., Dorr, M., Newton- Cheh, C., Nolte, I. M., van der Harst, P., Muller, M., Eijgelsheim, M., Alonso, A., Hicks, A. A., Padmanabhan, S., Hayward, C., Smith, A. V., Polasek, O., Giovannone, S., Fu, J. Y., Magnani, J. W., Marciante, K. D., Pfeufer, A., Gharib, S. A., Teumer, A., Li, M., Bis, J. C., Rivadeneira, F., Aspelund, T., Kottgen, A., Johnson, T., Rice, K., Sie, M. P. S., Wang, Y. A., Klopp, N., Fuchsberger, C., Wild, S. H., Leach, I. M., Estrada, K., Volker, U., Wright, A. F., Asselbergs, F. W., Qu, J. X., Chakravarti, A., Sinner, M. F., Kors, J. A., Petersmann, A., Harris, T. B., Soliman, E. Z., Munroe, P. B., Psaty, B. M., Oostra, B. A., Cupples, L. A., Perz, S., de Boer, R. A., Uitterlinden, A. G., Volzke, H., Spector, T. D., Liu, F. Y., Boerwinkle, E., Dominiczak, A. F., Rotter, J. I., van Herpen, G., Levy, D., Wichmann, H. E., van Gilst, W. H., Witteman, J. C. M., Kroemer, H. K., Kao, W. H. L., Heckbert, S. R., Meitinger, T., Hofman, A., Campbell, H., Folsom, A. R., van Veldhuisen, D. J., Schwienbacher, C., O'Donnell, C. J., Volpato, C. B., Caulfield, M. J., Connell, J. M., Launer, L., Lu, X. W., Franke, L., Fehrmann, R. S. N., Meerman, G. T., Groen, H. J. M., Weersma, R. K., van den Berg, L. H., Wijmenga, C., Ophoff, R. A., Navis, G., Rudan, I., Snieder, H., Wilson, J. F., Pramstaller, P. P., Siscovick, D. S., Wang, T. J., Gudnason, V., van Duijn, C. M., Felix, S. B., Fishman, G. I., Jamshidi, Y., Stricker, B. H. C., Samani, N. J., Kaab, S., Arking, D. E. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nature Genetics 42(12): U62, Stevens, L. A., Schmid, C. H., Greene, T., Zhang, Y. P., Beck, G. J., Froissart, M., Hamm, L. L., Lewis, J. B., Mauer, M., Navis, G. J., Steffes, M. W., Eggers, P. W., Coresh, J., Levey, A. S. Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 ml/min/1.73 m(2). American Journal of Kidney Diseases 56(3): , 6

7 Tabara, Y., Kohara, K., Kita, Y., Hirawa, N., Katsuya, T., Ohkubo, T., Hiura, Y., Tajima, A., Morisaki, T., Miyata, T., Nakayama, T., Takashima, N., Nakura, J., Kawamoto, R., Takahashi, N., Hata, A., Soma, M., Imai, Y., Kokubo, Y., Okamura, T., Tomoike, H., Iwai, N., Ogihara, T., Inoue, I., Tokunaga, K., Johnson, T., Caulfield, M., Munroe, P., Umemura, S., Ueshima, H., Miki, T. Common Variants in the ATP2B1 Gene Are Associated With Susceptibility to Hypertension The Japanese Millennium Genome Project. Hypertension 56(5): 973-U533, Tent, H., Rook, M., Stevens, L. A., van Son, W. J., van Pelt, L. J., Hofker, H. S., Ploeg, R. J., van der Heide, J. J. H., Navis, G. Renal Function Equations before and after Living Kidney Donation: A Within-Individual Comparison of Performance at Different Levels of Renal Function. Clinical Journal of the American Society of Nephrology 5(11): , Ulu, N., Gurdal, H., Landheer, S. W., Duin, M., Guc, M. O., Buikema, H., Henning, R. H. alpha(1)-adrenoceptor-mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptor. British Journal of Pharmacology 161(6): , van der Harst, P., Bakker, S. J. L., de Boer, R. A., Wolffenbuttel, B. H. R., Johnson, T., Caulfield, M. J., Navis, G. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Human Molecular Genetics 19(2): , van der Velde, M., Bakker, S. J. L., de Jong, P. E., Gansevoort, R. T. Influence of Age and Measure of egfr on the Association between Renal Function and Cardiovascular Events. Clinical Journal of the American Society of Nephrology 5(11): , Voorham, J., Haaijer-Ruskamp, F. M., van der Meer, K., de Zeeuw, D., Wolffenbuttel, B. H. R., Hoogenberg, K., Denig, P. Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to analyse Type 2 diabetes Treatment (GIANTT) observational study. Pharmacoepidemiology and Drug Safety 19(10): , Voorham, J., Haaijer-Ruskamp, F. M., Wolffenbuttel, B. H. R., Stolk, R. P., Denig, P. Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden. Quality & Safety in Health Care 19(5): , Voorham, J., Haaijer-Ruskamp, F. M., van der Meer, K., de Zeeuw, D., Wolffenbuttel, B. H. R., Hoogenberg, K., Denig, P. Quality of type 2 diabetes treatment: Results of the Giantt Project Nederlands Tijdschrift voor Geneeskunde 154(4): , Waanders, F., van Timmeren, M. M., Stegeman, C. A., Bakker, S. J. L., van Goor, H. Kidney injury molecule-1 in renal disease. Journal of Pathology 220(1): 7-16, Waanders, F., Navis, G., van Goor, H. Urinary Tubular Biomarkers of Kidney Damage: Potential Value in Clinical Practice. American Journal of Kidney Diseases 55(5): , Zelle, D. M., Corpeleijn, E., van Ree, R. M., Stolk, R. P., van der Veer, E., Gans, R. O. B., van der Heide, J. J. H., Navis, G., Bakker, S. J. L. Markers of the Hepatic Component of the Metabolic Syndrome as Predictors of Mortality in Renal Transplant Recipients. American Journal of Transplantation 10(1): , van der Velde, M., de Jong, P. E., Gansevoort, R. T. Comparison of the yield of different screening approaches to detect chronic kidney disease. Nephrology Dialysis Transplantation 25(10): , van Ree, R. M., Gross, S., Zelle, D. M., van der Heide, J. J. H., Schouten, J. P., van Son, W. J., Gans, R. O. B., Bakker, S. J. L. Influence of C-Reactive Protein and Urinary Protein Excretion on Prediction of Graft Failure and Mortality by Serum Albumin in Renal Transplant Recipients. Transplantation 89(10): , Vogt, L., Chiurchiu, C., Chadha-Boreham, H., Danaietash, P., Dingemanse, J., Hadjadj, S., Krum, H., Navis, G., Neuhart, E., Parvanova, A. I., Ruggenenti, P., Woittiez, A. J., Zimlichman, R., Remuzzi, G., de Zeeuw, D. Effect of the Urotensin Receptor Antagonist Palosuran in Hypertensive Patients With Type 2 Diabetic Nephropathy. Hypertension 55(5): , Vogt, L., Laverman, G. D., Navis, G. Time for a comeback of NSAIDs in proteinuric chronic kidney disease? Netherlands Journal of Medicine 68(12): , 7

8 CARDIOVASCULAIR CENTER - CVC Dissertations Ahmed, S. An update on amiodarone treatment for atrial fibrillation: efficacy versus safety. (2010) van Gelder, I. C., van Veldhuisen, D. J., and Links, T. P. Belonje, A. M. S. Endogenous and exogenous erythropoietin in left ventricular dysfunction. (2010) van Veldhuisen, D. J., van Gilst, W. H., and Voors, A. A. Kuipers, I. Liver X receptor in the cardiovascular system. (2010) van Gilst, W. H., van Veldhuisen, D. J., and de Boer, R. A. Loon, R. L. E. van. Paediatric pulmonary hypertension: epidemiology, characterisation and treatment. (2010) Berger, R. M. F., Hillege, H. L., and Mulder, B. J. M. Oeseburg, H. Cardiovascular Diseases. (2010) van Gilst, W. H., Silljé, H. W., de Boer, R. A., and van der Harst, P. Veeger, N. J. G. M. Individual approach towards optimal oral anticoagulation. (2010) Kluin-Nelemans, J. C. and Hillege, J. L. Liu, G. Genetic and environmental effects on obesity and insulin resistance : findings in youth. (2010) Snieder, H. Journal articles Aalberts, J. J. J., Schuurman, A. G., Pals, G., Hamel, B. J. C., Bosman, G., Hilhorst-Hofstee, Y., Barge-Schaapveld, D. Q. C. M., Mulder, B. J. M., van den Berg, M. P., van Tintelen, J. P. Recurrent and founder mutations in the Netherlands Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation. Netherlands Heart Journal 18(2): 85-89, Abbasi, A., Corpeleijn, E., Postmus, D., Gansevoort, R. T., de Jong, P. E., Gans, R. O. B., Struck, J., Hillege, H. L., Stolk, R. P., Navis, G., Bakker, S. J. L. Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic Syndrome. Journal of Clinical Endocrinology & Metabolism 95(9): E26-E31, Ahmed, S., Ranchor, A. V., Crijns, H. J. G. M., van Veldhuisen, D. J., van Gelder, I. C. Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation. Europace 12(6): , Arrigoni, S. C., Mecozzi, G., Zijlstra, F., Mariani, M. A. Aortic No- Touch Off-Pump Coronary Artery Bypass Grafting: A State-ofthe-Art Surgical Technique Reply. Annals of Thoracic Surgery 90(4): , Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., Theuns, D., Park, R. E., Wright, D. J., Connelly, D. T., Fynn, S. P., Murgatroyd, F. D., Sperzel, J., Neuzner, J., Spitzer, S. G., Ardashev, A. V., Oduro, A., Boersma, L., Maass, A. H., van Gelder, I. C., Wilde, A. A., van Dessel, P. F., Knops, R. E., Barr, C. S., Lupo, P., Cappato, R., Grace, A. A. An Entirely Subcutaneous Implantable Cardioverter-Defibrillator. New England Journal of Medicine 363(1): 36-44, Beijk, M. A. M., Boekholdt, S. M., Rittersma, S. Z. H., Pons, D., Zwinderman, A. H., Doevendans, P. A. F., Tio, R. A., Tijssen, J. G. P., Jukema, J. W., de Winter, R. J. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention. Pharmacogenetics and Genomics 20(9): , Bell, K. J. L., Hayen, A., Macaskill, P., Craig, J. C., Neal, B. C., Fox, K. M., Remme, W. J., Asselbergs, F. W., van Gilst, W. H., MacMahon, S., Remuzzi, G., Ruggenenti, P., Teo, K. K., Irwig, L. Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens An Individual Patient Data Meta- Analysis From Randomized, Placebo-Controlled Trials. Hypertension 56(3): 533-U429, Belonje, A. M. S., Voors, A. A., van der Meer, P., Jaarsma, T., van Veldhuisen, D. J., van Gilst, W. H. Response to Letter Regarding Article, "Endogenous Erythropoietin and Outcome in Heart Failure". Circulation 122(10): E450, Belonje, A. M. S., Voors, A. A., van der Meer, P., van Gilst, W. H., Jaarsma, T., van Veldhuisen, D. J. Endogenous Erythropoietin and Outcome in Heart Failure. Circulation 121(2): , Bentley, J. P., Asselbergs, F. W., Coffey, C. S., Hebert, P. R., Moore, J. H., Hillege, H. L., van Gilst, W. H. Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems. PLoS ONE 5(9 AR e12757 DI /journal.pone ) Berger, R. M. F., Beghetti, M., Galie, N., Gatzoulis, M. A., Granton, J., Lauer, A., Chiossi, E., Landzberg, M. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup analysis. International Journal of Cardiology 144(3): , 8

9 Boersma, C., Voors, A. A., Visser, S. T., de Jong-van den Berg, Postma, M. J. Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands A Comparative Analysis Using Clinical Trial and Drug Utilization Data. American Journal of Cardiovascular Drugs 10(1): 49-54, Bolling, M. C., Pas, H. H., de Visser, M., Aronica, E., Pfendner, E. G., van den Berg, M. P., Diercks, G. F. H., Suurmeijer, A. J. H., Jonkman, M. F. PLEC1 Mutations Underlie Adult-Onset Dilated Cardiomyopathy in Epidermolysis Bullosa Simplex with Muscular Dystrophy. Journal of Investigative Dermatology 130(4): , Bouma, W., van der Horst, I. C. C., Wijdh-den Hamer, I. J., Erasmus, M. E., Zijlstra, F., Mariani, M. A., Ebels, T. Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches. European Journal of Cardio-Thoracic Surgery 37(1): , Bouma, W., Wijdh-den Hamer, I. J., van der Horst, I. C. C., Mariani, M. A. Repair of chronic ischemic mitral regurgitation with posterior leaflet extension Reply. European Journal of Cardio- Thoracic Surgery 38(4): , Bouma, W., Klinkenberg, T. J., van der Horst, I. C. C., Wijdh-den Hamer, I. J., Erasmus, M. E., Bijl, M., Suurmeijer, A. J. H., Zijlstra, F., Mariani, M. A. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. Journal of Cardiothoracic Surgery 5 AR 13 DI / : 13, Brugemann, J., Kampinga, G. A., Riezebos-Brilman, A., Stek, C. J., Edel, J. P., van der Bij, W., Sprenger, H. G., Zijlstra, F. Two donorrelated infections in a heart transplant recipient: One common, the other a tropical surprise. Journal of Heart and Lung Transplantation 29(12): , Brugemann, J., Edel, J. P., Zijlstra, F. Clinical cardiac rehabilitation. Nederlands Tijdschrift voor Geneeskunde 154(12): , Chambers, J. C., Zhang, W. H., Lord, G. M., van der Harst, P., Lawlor, D. A., Sehmi, J. S., Gale, D. P., Wass, M. N., Ahmadi, K. R., Bakker, S. J. L., Beckmann, J., Bilo, H. J. G., Bochud, M., Brown, M. J., Caulfield, M. J., Connell, J. M. C., Cook, H. T., Cotlarciuc, I., Smith, G. D., de Silva, R., Deng, G. H., Devuyst, O., Dikkeschei, L. D., Dimkovic, N., Dockrell, M., Dominiczak, A., Ebrahim, S., Eggermann, T., Farrall, M., Ferrucci, L., Floege, J., Forouhi, N. G., Gansevoort, R. T., Han, X. J., Hedblad, B., van der Heide, J. J. H., Hepkema, B. G., Hernandez-Fuentes, M., Hypponen, E., Johnson, T., de Jong, P. E., Kleefstra, N., Lagou, V., Lapsley, M., Li, Y., Loos, R. J. F., Luan, J., Luttropp, K., Marechal, C., Melander, O., Munroe, P. B., Nordfors, L., Parsa, A., Peltonen, L., Penninx, B. W., Perucha, E., Pouta, A., Prokopenko, I., Roderick, P. J., Ruokonen, A., Samani, N. J., Sanna, S., Schalling, M., Schlessinger, D., Schlieper, G., Seelen, M. A. J., Shuldiner, A. R., Sjogren, M., Smit, J. H., Snieder, H., Soranzo, N., Spector, T. D., Stenvinkel, P., Sternberg, M. J. E., Swaminathan, R., Tanaka, T., Ubink-Veltmaat, L. J., Uda, M., Vollenweider, P., Wallace, C., Waterworth, D., Zerres, K., Waeber, G., Wareham, N. J., Maxwell, P. H., McCarthy, M. I., Jarvelin, M. R., Mooser, V., Abecasis, G. R., Lightstone, L., Scott, J., Navis, G., Elliott, P., Kooner, J. S. Genetic loci influencing kidney function and chronic kidney disease. Nature Genetics 42(5): , Christiaans, I., Nannenberg, E. A., Dooijes, D., Jongbloed, R. J. E., Michels, M., Postema, P. G., Majoor-Krakauer, D., van den Wijngaard, A., Mannens, M. M. A. M., van Tintelen, J. P., van Langen, I. M., Wilde, A. A. M. Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Netherlands Heart Journal 18(5): , Christiaans, I., Birnie, E., van Langen, I. M., Spaendonck-Zwarts, K. Y., van Tintelen, J. P., van den Berg, M. P., Atsma, D. E., Helderman-van den Enden, A. T. J. M., Pinto, Y. M., Hermans-van Ast, J. F., Bonsel, G. J., Wilde, A. A. M. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. European Heart Journal 31(7): , Codd, V., Mangino, M., van der Harst, P., Braund, P. S., Kaiser, M., Beveridge, A. J., Rafelt, S., Moore, J., Nelson, C., Soranzo, N., Zhai, G. J., Valdes, A. M., Blackburn, H., Leach, I. M., de Boer, R. A., Goodall, A. H., Ouwehand, W., van Veldhuisen, D. J., van Gilst, W. H., Navis, G., Burton, P. R., Tobin, M. D., Hall, A. S., Thompson, J. R., Spector, T., Samani, N. J. Common variants near TERC are associated with mean telomere length. Nature Genetics 42(3): , Coronel, R., Langerveld, J., Boersma, L. V. A., Wever, E. F. D., Bon, L., van Dessel, P. F. H. M., Linnenbank, A. C., van Gilst, W. H., Ernst, S. M. P. G., Opthof, T., van Hemel, N. M. Left atrial pressure reduction for mitral stenosis reverses left atrial directiondependent conduction abnormalities. Cardiovascular Research 85(4): , Cotter, G., Voors, A. A., Weatherley, B. D., Pang, P. S., Teerlink, J. R., Filippatos, G., Ponikowski, P., Milo-Cotter, O., Dittrich, H., Teichman, S. L., Adams, K. F., Gheorghiade, M., Metra, M. Acute Heart Failure Clinical Drug Development: From Planning to Proof of Activity to Phase III. Cardiology 116(4): , Damman, K., Voors, A. A., Hillege, H. L., Navis, G., Lechat, P., van Veldhuisen, D. J., Dargie, H. J. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. European Journal of Heart Failure 12(9): , Damman, K., van Veldhuisen, D. J., Navis, G., Vaidya, V. S., Smilde, T. D. J., Westenbrink, B. D., Bonventre, J. V., Voors, A. A., Hillege, H. L. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96(16): , 9

10 Davenport, A., Anker, S. D., Mebazaa, A., Palazzuoli, A., Vescovo, G., Bellomo, R., Ponikowski, P., Anand, I., Aspromonte, N., Bagshaw, S., Berl, T., Bobek, I., Cruz, D. N., Daliento, L., Haapio, M., Hillege, H., House, A., Katz, N., Maisel, A., Mankad, S., McCullough, P., Ronco, F., Shaw, A., Sheinfeld, G., Soni, S., Zamperetti, N., Zanco, P., Ronco, C. ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference. Nephrology Dialysis Transplantation 25(7): , de Boer, M. J., Ottervanger, J. P., Suryapranata, H., Hoorntje, J. C. A., Dambrink, J. H. E., Gosselink, A. T. M., van't Hof, A. W. J., Zijlstra, F. Old Age and Outcome After Primary Angioplasty for Acute Myocardial Infarction. Journal of the American Geriatrics Society 58(5): , de Boer, R. A., Doehner, W., van der Horst, I. C. C., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J., Flather, M. D., van Veldhuisen, D. J. Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients >= 70 Years Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure [SENIORS]). American Journal of Cardiology 106(1): 78-86, de Boer, R. A., Yu, L., van Veldhuisen, D. J. Galectin-3 in cardiac remodeling and heart failure. Current Heart Failure Reports 7(1): 1-8, de Boer, R. A., Martens, F. M., Kuipers, I., Boomsma, F., Visseren, F. L. The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus. Journal of Human Hypertension 24(1): 74-76, de Boer, S. P. M., Westerhout, C. M., Simes, R. J., Granger, C. B., Zijlstra, F., Boersma, E. Mortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's Age. JACC: Cardiovascular Interventions 3(3): , de Groot, N. M. S., Kirchhof, C. J., van Gelder, I. C., Meeder, J. G., Balk, A. H. M. M., Wilde, A. A., Simoons, M. L. Dronedarone in patients with atrial fibrillation. Netherlands Heart Journal 18(7-8): , De Smedt, R. H. E., Jaarsma, T., Haaijer-Ruskamp, F. M., Denig, P. The Impact of Perceived Adverse Effects on Medication Changes in Heart Failure Patients. Journal of Cardiac Failure 16(2): , Diercks, G. F., van Tintelen, J. P., Tio, R. A., Kerstjens-Frederikse, W. S., Pinto, Y. M., Suurmeijer, A. J. Ultrastructural pathology of the nuclear envelope in familial lamin A/C cardiomyopathy. Cardiovascular Pathology 19(4): e135-e136, Drenthen, W., Boersma, E., Balci, A., Moons, P., Roos-Hesselink, J. W., Mulder, B. J. M., Vliegen, H. W., van Dijk, A. P. J., Voors, A. A., Yap, S. C., van Veldhuisen, D. J., Pieper, P. G. Predictors of pregnancy complications in women with congenital heart disease. European Heart Journal 31(17): , Duffels, M. G. J., Mulder, K. M., Trip, M. D., de Groot, E., Gort, J., van Dijk, A. P. J., Hoendermis, E. S., Daliento, L., Zwinderman, A. H., Berger, R. M. F., Mulder, B. J. M. Atherosclerosis in Patients With Cyanotic Congenital Heart Disease. Circulation Journal 74(7): , Dullaart, R. P. F., Perton, F., Van Der Klauw, M. M., Hillege, H. L., Sluiter, W. J. High plasma lecithin: cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol. Atherosclerosis 208(2): , Eijgelsheim, M., Newton-Cheh, C., Sotoodehnia, N., de Bakker, P. I. W., Muller, M., Morrison, A. C., Smith, A. V., Isaacs, A., Sanna, S., Dorr, M., Navarro, P., Fuchsberger, C., Nolte, I. M., de Geus, E. J. C., Estrada, K., Hwang, S. J., Bis, J. C., Ruckert, I. M., Alonso, A., Launer, L. J., Hottenga, J. J., Rivadeneira, F., Noseworthy, P. A., Rice, K. M., Perz, S., Arking, D. E., Spector, T. D., Kors, J. A., Aulchenko, Y. S., Tarasov, K. V., Homuth, G., Wild, S. H., Marroni, F., Gieger, C., Licht, C. M., Prineas, R. J., Hofman, A., Rotter, J. I., Hicks, A. A., Ernst, F., Najjar, S. S., Wright, A. F., Peters, A., Fox, E. R., Oostra, B. A., Kroemer, H. K., Couper, D., Volzke, H., Campbell, H., Meitinger, T., Uda, M., Witteman, J. C. M., Psaty, B. M., Wichmann, H. E., Harris, T. B., Kaab, S., Siscovick, D. S., Jamshidi, Y., Uitterlinden, A. G., Folsom, A. R., Larson, M. G., Wilson, J. F., Penninx, B. W., Snieder, H., Pramstaller, P. P., van Duijn, C. M., Lakatta, E. G., Felix, S. B., Gudnason, V., Pfeufer, A., Heckbert, S. R., Stricker, B. H. C., Boerwinkle, E., O'Donnell, C. J. Genome-wide association analysis identifies multiple loci related to resting heart rate. Human Molecular Genetics 19(19): , Fortier, I., Burton, P. R., Robson, P. J., Ferretti, V., Little, J., L'Heureux, F., Deschenes, M., Knoppers, B. M., Doiron, D., Keers, J. C., Linksted, P., Harris, J. R., Lachance, G., Boileau, C., Pedersen, N. L., Hamilton, C. M., Hveem, K., Borugian, M. J., Gallagher, R. P., McLaughlin, J., Parker, L., Potter, J. D., Gallacher, J., Kaaks, R., Liu, B., Sprosen, T., Vilain, A., Atkinson, S. A., Rengifo, A., Morton, R., Metspalu, A., Wichmann, H. E., Tremblay, M., Chisholm, R. L., Garcia-Montero, A., Hillege, H., Litton, J. E., Palmer, L. J., Perola, M., Wolffenbuttel, B. H. R., Peltonen, L., Hudson, T. J. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. International Journal of Epidemiology 39(5): , Gheorghiade, M., Follath, F., Ponikowski, P., Barsuk, J. H., Blair, J. E. A., Cleland, J. G., Dickstein, K., Drazner, M. H., Fonarow, G. C., Jaarsma, T., Jondeau, G., Sendon, J. L., Mebazaa, A., Metra, M., Nieminen, M., Pang, P. S., Seferovic, P., Stevenson, L. W., van Veldhuisen, D. J., Zannad, F., Anker, S. D., Rhodes, A., McMurray, J. J. V., Filippatos, G. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of 10

11 Intensive Care Medicine. European Journal of Heart Failure 12(5): , Glaudemans, A. W. J. M., Slart, R. H. J. A., Bozzao, A., Bonanno, E., Arca, M., Dierckx, R. A. J. O., Signore, A. Molecular imaging in atherosclerosis. European Journal of Nuclear Medicine and Molecular Imaging 37(12): , Golestani, R., Wu, C., Tio, R. A., Zeebregts, C. J., Petrov, A. D., Beekman, F. J., Dierckx, R. A. J. O., Boersma, H. H., Slart, R. H. J. A. Small-animal SPECT and SPECT/CT: application in cardiovascular research. European Journal of Nuclear Medicine and Molecular Imaging 37(9): , Golestani, R., Tio, R. A., Zeebregts, C. J., Zeilstra, A., Dierckx, R. A., Boersma, H. H., Hillege, H. L., Slart, R. H. J. A. Abdominal aortic calcification detected by dual X-ray absorptiometry: A strong predictor for cardiovascular events. Annals of Medicine 42(7): , Gu, Y. L., van der Horst, I. C. C., Douglas, Y. L., Svilaas, T., Mariani, M. A., Zijlstra, F. Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Netherlands Heart Journal 18(7-8): , Gu, Y. L., Kampinga, M. A., Wieringa, W. G., Fokkema, M. L., Nijsten, M. W., Hillege, H. L., van den Heuvel, A. F. M., Tan, E. S., Pundziute, G., van der Werf, R., Guyomi, S. H., van der Horst, I. C. C., Zijlstra, F., de Smet, B. J. G. L. Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST- Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration The Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperfusion of ST-Segment Elevation Myocardial Infarction (CICERO) Trial. Circulation 122(25): , Haeck, J. D. E., Gu, Y. L., Vogelzang, M., Bilodeau, L., Krucoff, M. W., Tijssen, J. G. P., de Winter, R. J., Zijlstra, F., Koch, K. T. Feasibility and Applicability of Computer-Assisted Myocardial Blush Quantification After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Catheterization and Cardiovascular Interventions 75(5): , Haeck, J. D. E., Koch, K. T., Gu, Y. L., Bilodeau, L., Kuijt, W. J., Sjauw, K. D., Henriques, J. P. S., Baan, J., Vis, M. M., Verouden, N. J. W., Groenink, M., Piek, J. J., Tijssen, J. G. P., Krucoff, M. W., Zijlstra, F., de Winter, R. J. Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial. Netherlands Heart Journal 18(11): , Hartog, J. W. L., van de Wal, R. M., Schalkwijk, C. G., Miyata, T., Jaarsma, W., Plokker, H. W. T., van Wijk, L. M., Smit, A. J., van Veldhuisen, D. J., Voors, A. A. Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction. European Journal of Heart Failure 12(4): , Haver, V. G., Slart, R. H. J. A., Zeebregts, C. J., Peppelenbosch, M. P., Tio, R. A. Rupture of Vulnerable Atherosclerotic Plaques: MicroRNAs Conducting the Orchestra? Trends in Cardiovascular Medicine 20(2): 65-71, Heestermans, T., van't Hof, A. W. J., ten Berg, J. M., van Werkum, J. W., Boersma, E., Mosterd, A., Stella, P. R., van Zoelen, A. B., Gosselink, A. T. M., Kochman, W., Dill, T., Koopmans, P. C., van Houwelingen, G., Zijlstra, F., Hamm, C. The golden hour of prehospital reperfusion with triple antiplatelet therapy: A subanalysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy. American Heart Journal 160(6): , Hermus, L., Lefrandt, J. D., Tio, R. A., Breek, J. C., Zeebregts, C. J. Carotid plaque formation and serum biomarkers. Atherosclerosis 213(1): 21-29, Hesstermans, A. A. C. M., van Werkum, J. W., Zwart, B., Van Der Heyden, J. A., Kelder, J. C., Breet, N. J., van't Hof, A. W. J., Dambrink, J. H. E., Koolen, J. J., Brueren, B. R. G., Zijlstra, F., ten Berg, J. M. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome 27. Journal of Thrombosis and Haemostasis 8(11): , Hoekstra, M., Schoorl, M. A., van der Horst, I. C. C., Vogelzang, M., Wietasch, J. K. G., Zijlstra, F., Nijsten, M. W. N. Computer- Assisted Glucose Regulation During Rapid Step-Wise Increases of Parenteral Nutrition in Critically Ill Patients: A Proof of Concept Study. Journal of Parenteral and Enteral Nutrition 34(5): , Hoekstra, M., Vogelzang, M., Drost, J. T., Janse, M., Loef, B. G., van der Horst, I. C. C., Zijlstra, F., Nijsten, M. W. N. Implementation and evaluation of a nurse-centered computerized potassium regulation protocol in the intensive care unit - a before and after analysis. BMC Medical Informatics and Decision Making 10 AR 5 DI / : 5, Hoekstra, T., Lesman-Leegte, I., Van der Wal, M., Luttik, M. L., Jaarsma, T. Nurse-led interventions in heart failure care Patient and nurse perspectives. European Journal of Cardiovascular Nursing 9(4): , House, A. A., Anand, I., Bellomo, R., Cruz, D., Bobek, I., Anker, S. D., Aspromonte, N., Bagshaw, S., Berl, T., Daliento, L., Davenport, A., Haapio, M., Hillege, H., McCullough, P., Katz, N., Maisel, A., Mankad, S., Zanco, P., Mebazaa, A., Palazzuoli, A., Ronco, F., Shaw, A., Sheinfeld, G., Soni, S., Vescovo, G., Zamperetti, N., Ponikowski, P., Ronco, C. Definition and classification of Cardio- Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation 25(5): , 11

12 Hummel, Y. M., Klip, I. J. T., de Jong, R. M., Pieper, P. G., van Veldhuisen, D. J., Voors, A. A. Diastolic function measurements and diagnostic consequences: a comparison of pulsed waveand color-coded tissue Doppler imaging. Clinical Research in Cardiology 99(7): , Huzen, J., van der Harst, P., de Boer, R. A., Lesman-Leegte, I., Voors, A. A., van Gilst, W. H., Samani, N. J., Jaarsma, T., van Veldhuisen, D. J. Telomere length and psychological well-being in patients with chronic heart failure. Age and Ageing 39(2): , Huzen, J., de Boer, R. A., van Veldhuisen, D. J., van Gilst, W. H., van der Harst, P. The emerging role of telomere biology in cardiovascular disease. Frontiers in Bioscience-Landmark 15: 35-45, Hwang, B., Luttik, M. L., Dracup, K., Jaarsma, T. Family Caregiving for Patients With Heart Failure: Types of Care Provided and Gender Differences. Journal of Cardiac Failure 16(5): , Inglis, S. C., McMurray, J. J. V., Bohm, M., Schaufelberger, M., van Veldhuisen, D. J., Lindberg, M., Dunselman, P., Hjalmarson, A., Kjekshus, J., Waagstein, F., Wedel, H., Wikstrand, J. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). European Journal of Heart Failure 12(7): , Jaarsma, T., Lesman-Leegte, I., Hillege, H. L., Veeger, N. J., Sanderman, R., van Veldhuisen, D. J. Depression and the Usefulness of a Disease Management Program in Heart Failure Insights From the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) Study. Journal of the American College of Cardiology 55(17): , Jamshidi, Y., Nolte, I. M., Spector, T. D., Snieder, H. Novel genes for QTc interval. How much heritability is explained, and how much is left to find? Genome Medicine 2(5) Kampinga, M. A., Nijsten, M. W. N., Gu, Y. L. L., Dijk, W. A., de Smet, B. J. G. L., van den Heuvel, A. F. M., Tan, E. S., Zijlstra, F. Is the Myocardial Blush Grade Scored by the Operator During Primary Percutaneous Coronary Intervention of Prognostic Value in Patients With ST-Elevation Myocardial Infarction in Routine Clinical Practice? Circulation-Cardiovascular Interventions 3(3): 216-U35, Kristanto, W., van Ooijen, P. M., Dikkers, R., Greuter, M. J., Zijlstra, F., Oudkerk, M. Quantitative image analysis for the detection of motion artefacts in coronary artery computed tomography. International Journal of Cardiovascular Imaging 26(1): 77-87, Kuipers, I., Li, J. A., Vreeswijk-Baudoin, I., Koster, J., van der Harst, P., Sillje, H. H. W., Kuipers, F., van Veldhuisen, D. J., van Gilst, W. H., de Boer, R. A. Activation of liver X receptors with T attenuates cardiac hypertrophy in vivo. European Journal of Heart Failure 12(10): , Kuipers, I., van der Harst, P., Kuipers, F., van Genne, L., Goris, M., Lehtonen, J. Y., van Veldhuisen, D. J., van Gilst, W. H., de Boer, R. A. Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system. Laboratory Investigation 90(4): , Kuznetsova, T., Codd, V., Brouilette, S., Thijs, L., Gonzalez, A., Jin, Y., Richart, T., van der Harst, P., Diez, J., Staessen, J. A., Samani, N. J. Association Between Left Ventricular Mass and Telomere Length in a Population Study. American Journal of Epidemiology 172(4): , Leach, I. M., van der Harst, P., de Boer, R. A. Pharmacoepigenetics in heart failure. Current Heart Failure Reports 7(2): 83-90, Leclercq, C., Padeletti, L., Cihak, R., Ritter, P., Milasinovic, G., Gras, D., Paul, V., van Gelder, I. C., Stellbrink, C., Rieger, G., Corbucci, G., Albers, B., Daubert, J. C. Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace 12(1): 71-77, Lee, J., Chen, L., Snieder, H., Chen, D. F., Lee, L. M., Liu, G. F., Wu, T., Tang, X., Zhan, S. Y., Cao, W. H., Lv, J., Gao, W. J., Hu, Y. H. Heritability of Obesity-related Phenotypes and Association with Adiponectin Gene Polymorphisms in the Chinese National Twin Registry. Annals of Human Genetics 74(2): , Li, Z. B., Snieder, H., Su, S. Y., Harshfield, G. A., Treiber, F. A., Wang, X. L. A longitudinal study of blood pressure variability in African- American and European American youth. Journal of Hypertension 28(4): , Liem, E. T., Vonk, J. M., Sauer, P. J. J., van der Steege, G., Oosterom, E., Stolk, R. P., Snieder, H. Influence of common variants near INSIG2, in FTO, and near MC4R genes on overweight and the metabolic profile in adolescence: the TRAILS (TRacking Adolescents' Individual Lives Survey) Study. American Journal of Clinical Nutrition 91(2): , Linssen, G. C. M., Bakker, S. J. L., Voors, A. A., Gansevoort, R. T., Hillege, H. L., de Jong, P. E., van Veldhuisen, D. J., Gans, R. O. B., de Zeeuw, D. N-terminal pro-b-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. European Heart Journal 31(1): , Linssen, G. C. M., Damman, K., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., Navis, G. Letter by van Kimmenade et al Regarding Article, "Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure" Response. Circulation 121(10): E243, 12

13 Lipsic, E., van Veldhuisen, D. J. Nebivolol in chronic heart failure: current evidence and future perspectives. Expert Opinion on Pharmacotherapy 11(6): , Liu, G. F., Zhu, H. D., Lagou, V., Gutin, B., Stallmann-Jorgensen, I. S., Treiber, F. A., Dong, Y. B., Snieder, H. FTO variant rs is associated with body mass index and waist circumference, but not with energy intake or physical activity in European- and African-American youth. BMC Medical Genetics 11 AR 57 DI / (1): 57, Liu, G. F., Zhu, H. D., Lagou, V., Gutin, B., Barbeau, P., Treiber, F. A., Dong, Y. B., Snieder, H. Common Variants Near Melanocortin 4 Receptor Are Associated with General and Visceral Adiposity in European- and African-American Youth. Journal of Pediatrics 156(4): 598-U99, Lok, D. J. A., van der Meer, P., Bruggink-Andre de la Porte, Lipsic, E., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clinical Research in Cardiology 99(5): , Lorgelly, P. K., Briggs, A. H., Wedel, H., Dunselman, P., Hjalmarson, A., Kjekshus, J., Waagstein, F., Wikstrand, J., Janosi, A., van Veldhuisen, D. J., Barrios, V., Fonseca, C., McMurray, J. J. V. An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. European Journal of Heart Failure 12(1): 66-74, Lu, B., Mahmud, H., Maass, A. H., Yu, B., van Gilst, W. H., de Boer, R. A., Sillje, H. H. W. The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro. PLoS ONE 5(9 AR e12963 DI /journal.pone ) Maass, A. H., de Jong, A. M. R., Smit, M. D., Gouweleeuw, L., de Boer, R. A., van Gilst, W. H., van Gelder, I. C. Cardiac gene expression profiling - the quest for an atrium-specific biomarker. Netherlands Heart Journal 18(12): , Maass, A. H., van Veldhuisen, D. J. Device therapy in patients with heart failure and preserved ejection fraction (HFPEF): a new frontier? European Journal of Heart Failure 12(6): , Maggioni, A. P., Dahlstrom, U., Filippatos, G., Chioncel, O., Leiro, M. C., Drozdz, J., Fruhwald, F., Gullestad, L., Logeart, D., Metra, M., Parissis, J., Persson, H., Ponikowski, P., Rauchhaus, M., Voors, A., Nielsen, O. W., Zannad, F., Tavazzi, L. EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart Failure 12(10): , Massie, B. M., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Weatherley, B. D., Cleland, J. G. F., Givertz, M. M., Voors, A., DeLucca, P., Mansoor, G. A., Salerno, C. M., Bloomfield, D. M., Dittrich, H. C. Rolofylline, an Adenosine A(sub 1)-Receptor Antagonist, in Acute Heart Failure. New England Journal of Medicine 363(15): , McCullough, P. A., Haapio, M., Mankad, S., Zamperetti, N., Massie, B., Bellomo, R., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bobek, I., Cruz, D. N., Daliento, L., Davenport, A., Hillege, H., House, A. A., Katz, N., Maisel, A., Mebazaa, A., Palazzuoli, A., Ponikowski, P., Ronco, F., Shaw, A., Sheinfeld, G., Soni, S., Vescovo, G., Zanco, P., Ronco, C., Berl, T. Prevention of cardiorenal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation 25(6): , Meerwaldt, R., Slart, R. H. J. A., van Dam, G. M., Luijckx, G. J., Tio, R. A., Zeebregts, C. J. PET/SPECT imaging: From carotid vulnerability to brain viability. European Journal of Radiology 74(1): , Metra, M., Cleland, J. G., Weatherley, B. D., Dittrich, H. C., Givertz, M. M., Massie, B. M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Voors, A. A., Cotter, G. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. European Journal of Heart Failure 12(5): , Metra, M., Teerlink, J. R., Felker, G. M., Greenberg, B. H., Filippatos, G., Ponikowski, P., Teichman, S. L., Unemori, E., Voors, A. A., Weatherley, B. D., Cotter, G. Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre- RELAX-AHF study. European Journal of Heart Failure 12(10): , Metra, M., Felker, G. M., Zaca, V., Bugatti, S., Lombardi, C., Bettari, L., Voors, A. A., Gheorghiade, M., Cas, L. D. Acute heart failure: Multiple clinical profiles and mechanisms require tailored therapy. International Journal of Cardiology 144(2): , Milo-Cotter, O., Bettari, L., Kleijn, L., Bugatti, S., Lombardi, C., Rund, M., Metra, M., Voors, A. A., Cotter, G., Kaluski, E., Weatherley, B. D. The management of acute heart failure. Panminerva Medica 52(1): 53-66, Monraats, P. S., Fang, Y., Pons, D., Pires, N. M. M., Pols, H. A. P., Zwinderman, A. H., de Maat, M. P. M., Doevendans, P. A. F., Dewinter, R. J., Tio, R. A., Waltenberger, J., Frants, R. R., Quax, P. H. A., van der Laarse, A., van der Wall, E. E., Uitterlinden, A. G., Jukema, J. W. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention. Expert Opinion on Therapeutic Targets 14(3): , Muller, M., de Jong, M., Jaarsma, T., Koops, A., Voors, A. A., Nieuwenhuis, J. A., Wijkstra, P. J. Central sleep apnoea syndrome in chronic heart failure: an underestimated and treatable comorbidity. Netherlands Heart Journal 18(5): , 13

14 Navis, G., Bakker, S. J. L., van der Harst, P. Dissecting the genetics of complex traits: lessons from hypertension(*). Nephrology Dialysis Transplantation 25(5): , Nawrot, T. S., van der Harst, P., Staessen, J. A. Online journals: paying or delaying? Lancet 375(9719): 984, Ngo, K., Kotecha, D., Walters, J. A. E., Manzano, L., Palazzuoli, A., van Veldhuisen, D. J., Flather, M. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database of Systematic Reviews (1 AR CD DI / CD pub2) Oeseburg, H., de Boer, R. A., Buikema, H., van der Harst, P., van Gilst, W. H., Sillje, H. H. W. Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species-Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A. Arteriosclerosis Thrombosis and Vascular Biology 30(7): 1407-U356, Oeseburg, H., de Boer, R. A., van Gilst, W. H., van der Harst, P. Telomere biology in healthy aging and disease. Pflugers Archiv- European Journal of Physiology 459(2): , Otten, E., Asimaki, A., Maass, A., van Langen, I. M., van der Wal, A., de Jonge, N., van den Berg, M. P., Saffitz, J. E., Wilde, A. A. M., Jongbloed, J. D. H., van Tintelen, J. P. Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm 7(8): , Otten, E., Deprez, R. H. L. D., Weiss, M. M., van Slegtenhorst, M., Joosten, M., van der Smagt, J. J., de Jonge, N., Kerstjens- Frederikse, W. S., Roofthooft, M. T. R., Balk, A. H. M. M., van den Berg, M. P., Ruiter, J. S., van Tintelen, J. P. Recurrent and founder mutations in the Netherlands: mutation p.k217del in troponin T2, causing dilated cardiomyopathy. Netherlands Heart Journal 18(10): , Padmanabhan, S., Melander, O., Johnson, T., Di Blasio, A. M., Lee, W. K., Gentilini, D., Hastie, C. E., Menni, C., Monti, M. C., Delles, C., Laing, S., Corso, B., Navis, G., Kwakernaak, A. J., van der Harst, P., Bochud, M., Maillard, M., Burnier, M., Hedner, T., Kjeldsen, S., Wahlstrand, B., Sjogren, M., Fava, C., Montagnana, M., Danese, E., Torffvit, O., Hedblad, B., Snieder, H., Connell, J. M. C., Brown, M., Samani, N. J., Farrall, M., Cesana, G., Mancia, G., Signorini, S., Grassi, G., Eyheramendy, S., Wichmann, H. E., Laan, M., Strachan, D. P., Sever, P., Shields, D. C., Stanton, A., Vollenweider, P., Teumer, A., Volzke, H., Rettig, R., Newton- Cheh, C., Arora, P., Zhang, F., Soranzo, N., Spector, T. D., Lucas, G., Kathiresan, S., Siscovick, D. S., Luan, J. A., Loos, R. J. F., Wareham, N. J., Penninx, B. W., Nolte, I. M., McBride, M., Miller, W. H., Nicklin, S. A., Baker, A. H., Graham, D., McDonald, R. A., Pell, J. P., Sattar, N., Welsh, P., Munroe, P., Caulfield, M. J., Zanchetti, A., Dominiczak, A. F. Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension. PLoS Genetics 6(10 AR e DI /journal.pgen ) Pose, P. N., Kuijpers, M., Ebels, T., Zijlstra, F. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. European Heart Journal 31(16): , Procter, M., Suter, T. M., de Azambuja, E., Dafni, U., van Dooren, V., Muehlbauer, S., Climent, M. A., Rechberger, E., Liu, W. T. W., Toi, M., Coombes, R. C., Dodwell, D., Pagani, O., Madrid, J., Hall, M., Chen, S. C., Focan, C., Muschol, M., van Veldhuisen, D. J., Piccart- Gebhart, M. J. Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial. Journal of Clinical Oncology 28(21): , Queiroz, K. C. S., Tio, R. A., Zeebregts, C. J., Bijlsma, M. F., Zijlstra, F., Badlou, B., de Vries, M., Ferreira, C. V., Spek, C. A., Peppelenbosch, M. P., Rezaee, F. Human Plasma Very Low Density Lipoprotein Carries Indian Hedgehog. Journal of Proteome Research 9(11): , Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., Daliento, L., Davenport, A., Haapio, M., Hillege, H., House, A. A., Katz, N., Maisel, A., Mankad, S., Zanco, P., Mebazaa, A., Palazzuoli, A., Ronco, F., Shaw, A., Sheinfeld, G., Soni, S., Vescovo, G., Zamperetti, N., Ponikowski, P. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. European Heart Journal 31(6): C, Ruifrok, W. P. T., Lipsic, E., de Boer, R. A., van Gilst, W. H., van Veldhuisen, D. J. Erythropoiesis Stimulation in Acute Ischemic Syndromes. Heart Failure Clinics 6(3): , Ruifrok, W. T., Westenbrink, B. D., de Boer, R. A., den Hamer, I. J., Erasmus, M. E., Mungroop, H. E., Epema, A. H., Voors, A. A., van Veldhuisen, D. J., van Gilst, W. H. Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium. Netherlands Heart Journal 18(5): , Ruiter, J. S., Berkenbosch-Nieuwhof, K., van den Berg, M. P., van Dijk, R., Middel, B., van Tintelen, J. P. The Importance of the Family History in Caring for Families With Long QT Syndrome and Dilated Cardiomyopathy. American Journal of Medical Genetics Part A 152A(3): , Schirmer, S. H., Baumhakel, M., Neuberger, H. R., Hohnloser, S. H., van Gelder, I. C., Lip, G. Y. H., Bohm, M. Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Current Clinical Evidence and Future Developments. Journal of the American College of Cardiology 56(25): , Slart, R. H. J. A., Tio, R. A., van der Vleuten, P. A., Willems, T. P., Lubbers, D. D., Dierckx, R. A., van Veldhuisen, D. J. Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. Journal of Nuclear Cardiology 17(3): , 14

15 Sliwa, K., Hilfiker-Kleiner, D., Petrie, M. C., Mebazaa, A., Pieske, B., Buchmann, E., Regitz-Zagrosek, V., Schaufelberger, M., Tavazzi, L., van Veldhuisen, D. J., Watkins, H., Shah, A. J., Seferovic, P. M., Elkayam, U., Pankuweit, S., Papp, Z., Mouquet, F., McMurray, J. J. V. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure 12(8): , Smit, M. D., van Veldhuisen, D. J., van Gelder, I. C. Guidelines for Atrial Fibrillation in Heart Failure Need To Be Clarified. Journal of the American College of Cardiology 55(2): 167, Smit, M. D., Tio, R. A., Slart, R. H. J. A., Zijlstra, F., van Gelder, I. C. Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation. Europace 12(5): , Sofat, R., Hingorani, A. D., Smeeth, L., Humphries, S. E., Talmud, P. J., Cooper, J., Shah, T., Sandhu, M. S., Ricketts, S. L., Boekholdt, S. M., Wareham, N., Khaw, K. T., Kumari, M., Kivimaki, M., Marmot, M., Asselbergs, F. W., van der Harst, P., Dullaart, R. P. F., Navis, G., van Veldhuisen, D. J., van Gilst, W. H., Thompson, J. F., McCaskie, P., Palmer, L. J., Arca, M., Quagliarini, F., Gaudio, C., Cambien, F., Nicaud, V., Poirer, O., Gudnason, V., Isaacs, A., Witteman, J. C. M., van Duijn, C. M., Pencina, M., Vasan, R. S., D'Agostino, R. B., Ordovas, J., Li, T. Y., Kakko, S., Kauma, H., Savolainen, M. J., Kesaniemi, Y. A., Sandhofer, A., Paulweber, B., Sorli, J. V., Goto, A., Yokoyama, S., Okumura, K., Horne, B. D., Packard, C., Freeman, D., Ford, I., Sattar, N., McCormack, V., Lawlor, D. A., Ebrahim, S., Smith, G. D., Kastelein, J. J. P., Deanfield, J., Casas, J. P. Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms. Circulation 121(1): 52-62, Sotoodehnia, N., Isaacs, A., de Bakker, P. I. W., Dorr, M., Newton- Cheh, C., Nolte, I. M., van der Harst, P., Muller, M., Eijgelsheim, M., Alonso, A., Hicks, A. A., Padmanabhan, S., Hayward, C., Smith, A. V., Polasek, O., Giovannone, S., Fu, J. Y., Magnani, J. W., Marciante, K. D., Pfeufer, A., Gharib, S. A., Teumer, A., Li, M., Bis, J. C., Rivadeneira, F., Aspelund, T., Kottgen, A., Johnson, T., Rice, K., Sie, M. P. S., Wang, Y. A., Klopp, N., Fuchsberger, C., Wild, S. H., Leach, I. M., Estrada, K., Volker, U., Wright, A. F., Asselbergs, F. W., Qu, J. X., Chakravarti, A., Sinner, M. F., Kors, J. A., Petersmann, A., Harris, T. B., Soliman, E. Z., Munroe, P. B., Psaty, B. M., Oostra, B. A., Cupples, L. A., Perz, S., de Boer, R. A., Uitterlinden, A. G., Volzke, H., Spector, T. D., Liu, F. Y., Boerwinkle, E., Dominiczak, A. F., Rotter, J. I., van Herpen, G., Levy, D., Wichmann, H. E., van Gilst, W. H., Witteman, J. C. M., Kroemer, H. K., Kao, W. H. L., Heckbert, S. R., Meitinger, T., Hofman, A., Campbell, H., Folsom, A. R., van Veldhuisen, D. J., Schwienbacher, C., O'Donnell, C. J., Volpato, C. B., Caulfield, M. J., Connell, J. M., Launer, L., Lu, X. W., Franke, L., Fehrmann, R. S. N., Meerman, G. T., Groen, H. J. M., Weersma, R. K., van den Berg, L. H., Wijmenga, C., Ophoff, R. A., Navis, G., Rudan, I., Snieder, H., Wilson, J. F., Pramstaller, P. P., Siscovick, D. S., Wang, T. J., Gudnason, V., van Duijn, C. M., Felix, S. B., Fishman, G. I., Jamshidi, Y., Stricker, B. H. C., Samani, N. J., Kaab, S., Arking, D. E. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nature Genetics 42(12): U62, Spaendonck-Zwarts, K. Y., van Tintelen, J. P., van Veldhuisen, D. J., van der Werf, R., Jongbloed, J. D. H., Paulus, W. J., Dooijes, D., van den Berg, M. P. Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy. Circulation 121(20): , Su, S. Y., Lampert, R., Lee, F., Bremner, J. D., Snieder, H., Jones, L., Murrah, N. V., Goldberg, J., Vaccarino, V. Common Genes Contribute to Depressive Symptoms and Heart Rate Variability: The Twins Heart Study. Twin Research and Human Genetics 13(1): 1-9, Tan, E. S., van der Vleuten, P. A., Jessurun, G. A. J., Tio, R. A., Zijlstra, F., van Gelder, I. C. Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography. Netherlands Heart Journal 18(2): 72-77, Timmer, J. R., Breet, N., Svilaas, T., Haaksma, J., van Gelder, I. C., Zijlstra, F. Predictors of ventricular tachyarrhythmia in high-risk myocardial infarction patients treated with primary coronary intervention. Netherlands Heart Journal 18(3): , Tomaszewski, M., Debiec, R., Braund, P. S., Nelson, C. P., Hardwick, R., Christofidou, P., Denniff, M., Codd, V., Rafelt, S., van der Harst, P., Waterworth, D., Song, K. J., Vollenweider, P., Waeber, G., Zukowska-Szczechowska, E., Burton, P. R., Mooser, V., Charchar, F. J., Thompson, J. R., Tobin, M. D., Samani, N. J. Genetic Architecture of Ambulatory Blood Pressure in the General Population Insights From Cardiovascular Gene-Centric Array 35. Hypertension 56(6): , Ukena, C., Mahfoud, F., Kindermann, M., Kindermann, I., Bals, R., Voors, A. A., van Veldhuisen, D. J., Bohm, M. The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease. International Journal of Cardiology 145(2): , van Albada, M. E., Bartelds, B., Wijnberg, H., Mohaupt, S., Dickinson, M. G., Schoemaker, R. G., Kooi, K., Gerbens, F., Berger, R. M. F. Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions. American Journal of Physiology-Lung Cellular and Molecular Physiology 298(4): L483-L491, Van de Ven, L. L. M., van Veldhuisen, D. J., Goulder, M., Zilahi, Z., Meyer, W. R., Willenheimer, R. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure. International Journal of Cardiology 144(1): 59-63, van den Berg, M. P., Spaendonck-Zwarts, K. Y., van Veldhuisen, D. J. Dilated Cardiomyopathy Complicates Pregnancy Outcome: But 15

16 How? Journal of the American College of Cardiology 55(20): 2291, van den Berg, M. P., Spaendonck-Zwarts, K. Y., van Veldhuisen, D. J., Gietema, J. A., Postma, A., van Tintelen, J. P. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity? European Journal of Heart Failure 12(12): , van der Bom, T., Winter, M. M., Bouma, B. J., Groenink, M., Vliegen, H. W., Pieper, P. G., van Dijk, A. P. J., Sieswerda, G. T., Roos-Hesslink, J. W., Zwinderman, A. H., Mulder, B. J. M. Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle. American Heart Journal 160(5): , van der Harst, P., Slart, R. H. J. A., Tio, R. A., Dunselman, P. H. J. M., Willemsen, A. T. M., van den Heuvel, A. F. M., Voors, A. A., van Veldhuisen, D. J. Effects of Rosuvastatin on Coronary Flow Reserve and Metabolic Mismatch in Patients With Heart Failure (from the CORONA Study). American Journal of Cardiology 105(4): , van der Harst, P., de Boer, R. A., Samani, N. J., Wong, L. S. M., Huzen, J., Codd, V., Hillege, H. L., Voors, A. A., van Gilst, W. H., Jaarsma, T., van Veldhuisen, D. J. Telomere length and outcome in heart failure. Annals of Medicine 42(1): 36-44, van der Harst, P., Bakker, S. J. L., de Boer, R. A., Wolffenbuttel, B. H. R., Johnson, T., Caulfield, M. J., Navis, G. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Human Molecular Genetics 19(2): , van der Horst, I. C. C., de Boer, R. A., Hillege, H. L., Boomsma, F., Voors, A. A., van Veldhuisen, D. J. Neurohormonal profile of patients with heart failure and diabetes. Netherlands Heart Journal 18(4): , van der Meer, P., Lipsic, E., van Veldhuisen, D. J. Asialoerythropoietin to Protect the Failing Heart Is it Possible to Run With the Hare and Hunt With the Hounds? Journal of the American College of Cardiology 56(23): , van der Wal, M. H. L., van Veldhuisen, D. J., Veeger, N. J. G. M., Rutten, F. H., Jaarsma, T. Compliance with non-pharmacological recommendations and outcome in heart failure patients. European Heart Journal 31(12): , van der Wal, M. H. L., Jaarsma, T., Moser, D. K., van Gilst, W. H., van Veldhuisen, D. J. Qualitative examination of compliance in heart failure patients in The Netherlands. Heart & Lung 39(2): , van Deursen, V. M., Damman, K., Hillege, H. L., van Beek, A. P., van Veldhuisen, D. J., Voors, A. A. Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure Patients. Journal of Cardiac Failure 16(1): 84-90, van Gelder, I. C., Crijns, H. J. G. M., van den Berg, M. P. Lenient versus Strict Rate Control in Atrial Fibrillation REPLY. New England Journal of Medicine 363(4): , van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., van Veldhuisen, D. J., van den Berg, M. P. Lenient versus Strict Rate Control in Patients with Atrial Fibrillation. New England Journal of Medicine 362(15): , van Loon, R. L. E., Roofthooft, M. T. R., Delhaas, T., Osch-Gevers, M., ten Harkel, A. D. J., Strengers, J. L. M., Backx, A., Hillege, H. L., Berger, R. M. F. Outcome of Pediatric Patients With Pulmonary Arterial Hypertension in the Era of New Medical Therapies. American Journal of Cardiology 106(1): , van Melle, J. P., van der Vleuten, P. A., Hummel, Y. M., Nijveldt, R., Tio, R. A., Voors, A. A., Zijlstra, F. Predictive value of tissue Doppler imaging for left ventricular ejection fraction, remodelling, and infarct size after percutaneous coronary intervention for acute myocardial infarction. European Journal of Echocardiography 11(7): , van Melle, J. P., Bot, M., de Jonge, P., de Boer, R. A., van Veldhuisen, D. J., Whooley, M. A. Diabetes, Glycemic Control, and New- Onset Heart Failure in Patients With Stable Coronary Artery Disease Data from the Heart and Soul Study. Diabetes Care 33(9): , Veeger, N. J. G. M., Zijlstra, F., Hillege, H. L., van der Meer, J. Fourteen-Year Follow-Up From CABADAS: Vitamin K Antagonists or Dipyridamole Not Superior to Aspirin. Annals of Thoracic Surgery 90(5): 1515-U527, Verheugt, C. L., Uiterwaal, C. S. P. M., van der Velde, E. T., Meijboom, F. J., Pieper, P. G., van Dijk, A. P. J., Vliegen, H. W., Grobbee, D. E., Mulder, B. J. M. Mortality in adult congenital heart disease. European Heart Journal 31(10): , Verheugt, C. L., Uiterwaal, C. S. P. M., van der Velde, E. T., Meijboom, F. J., Pieper, P. G., Sieswerda, G. T., Plokker, H. W. M., Grobbee, D. E., Mulder, B. J. M. The emerging burden of hospital admissions of adults with congenital heart disease. Heart 96(11): , Vermeulen, R. P., Hoekstra, M., Nijsten, M. W. N., van der Horst, I. C., van Pelt, L. J., Jessurun, G. A., Jaarsma, T., Zijlstra, F., van den Heuvel, A. F. Clinical correlates of arterial lactate levels in patients with ST-segment elevation myocardial infarction at admission: a descriptive study. Critical Care 14(5 AR R164 DI /cc9253) Vonk, W. I. M., Wijmenga, C., Berger, R., van de Sluis, B., Klomp, L. W. J. Cu,Zn Superoxide Dismutase Maturation and Activity Are Regulated by COMMD1. Journal of Biological Chemistry 285(37): , 16

17 Voors, A. A., van de Wal, R. M., Hartog, J. W. L., Vijn, R. G., Hummel, Y. M., Plokker, T. W. M., van Veldhuisen, D. J., Jaarsma, W. Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction. Cardiovascular Drugs and Therapy 24(1): 33-40, Voors, A. A., Belonje, A. M. S., Zijlstra, F., Hillege, H. L., Anker, S. D., Slart, R. H. J. A., Tio, R. A., Van't Hof, A., Jukema, J. W., Peels, H. O. J., Henriques, J. P. S., ten Berg, J. M., Vos, J., van Gilst, W. H., van Veldhuisen, D. J. A single dose of erythropoietin in STelevation myocardial infarction. European Heart Journal 31(21): , Voors, A. A., van Veldhuisen, D. J. Cardiorenal Effects of Recombinant Human Natriuretic Peptides. Journal of the American College of Cardiology 55(17): , Wang, X. L., Zhu, H. D., Snieder, H., Su, S. Y., Munn, D., Harshfield, G., Maria, B. L., Dong, Y. B., Treiber, F., Gutin, B., Shi, H. D. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Medicine 8 AR 87 DI / Wang, Y., Qian, C., Roks, A. J. M., Westermann, D., Schumacher, S. M., Escher, F., Schoemaker, R. G., Reudelhuber, T. L., van Gilst, W. H., Schultheiss, H. P., Tschope, C., Walther, T. Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction. Circulation-Heart Failure 3(2): , Westenbrink, B. D., Voors, A. A., de Boer, R. A., Schuringa, J. J., Klinkenberg, T., van der Harst, P., Vellenga, E., van Veldhuisen, D. J., van Gilst, W. H. Bone marrow dysfunction in chronic heart failure patients. European Journal of Heart Failure 12(7): , Westenbrink, B. D., Ruifrok, W. P. T., Voors, A. A., Tilton, R. G., van Veldhuisen, D. J., Schoemaker, R. G., van Gilst, W. H., de Boer, R. A. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovascular Research 87(1): 30-39, Willemsen, S., Hartog, J. W. L., Hummel, Y. M., Posma, J. L., van Wijk, L. M., van Veldhuisen, D. J., Voors, A. A. Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial. European Journal of Heart Failure 12(3): , Winter, M. M., Reisma, C., Kedde, H., Bouma, B. J., Vis, J. C., Luijendijk, P., de Witte, P., Zwinderman, A. H., Vliegen, H. W., Pieper, P. G., van Dijk, A. P. J., Mulder, B. J. M. Sexuality in Adult Patients With Congenital Heart Disease and Their Partners. American Journal of Cardiology 106(8): , Wong, L. S. M., van der Harst, P., de Boer, R. A., Huzen, J., van Gilst, W. H., van Veldhuisen, D. J. Aging, telomeres and heart failure. Heart Failure Reviews 15(5): , Wong, L. S. M., Huzen, J., van der Harst, P., de Boer, R. A., Codd, V., Westenbrink, B. D., Benus, G. F. J. D., Voors, A. A., van Gilst, W. H., Samani, N. J., Jaarsma, T., van Veldhuisen, D. J. Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure. European Journal of Heart Failure 12(4): , Wu, T., Boezen, H. M., Postma, D. S., Los, H., Postmus, P. E., Snieder, H., Boomsma, D. I. Genetic and environmental influences on objective intermediate asthma phenotypes in Dutch twins. European Respiratory Journal 36(2): , Wu, T., Snieder, H., de Geus, E. Genetic influences on cardiovascular stress reactivity. Neuroscience and Biobehavioral Reviews 35(1): 58-68, Yap, S. C., Drenthen, W., Pieper, P. G., Moons, P., Mulder, B. J. M., Vliegen, H. W., van Dijk, A. P. J., Meijboom, F. J., Jaddoe, V. W. V., Steegers, E. A. P., Boersma, E., Roos-Hesselink, J. W. Pregnancy outcome in women with repaired versus unrepaired isolated ventricular septal defect. Bjog - an International Journal of Obstetrics and Gynaecology 117(6): , Zannad, F., McMurray, J. J. V., Drexler, H., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pitt, B. Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure 12(6): , 17

18 GRONINGEN RESEARCH INSTITUTE FOR ASTHMA AND COPD - GRIAC Dissertations Blacquière, M. J. Effects of environmental exposures on asthma phenotypes in the mouse : contributing and protecting mechanisms. (2010) Timens, W., Postma, D. S., and Hylkema, M. N. Bottema, R. W. B. Complex pathways to atopy development. Genes and environment. (2010) Postma, D. S., Schayck, C. P. van, and Kerkhof, M. Brouwer, A. F. J. Usefulness of home spirometry in childhood asthma. (2010) Duiverman, E. J. and Brand, P. L. P. Lapperre, T. S. Airway pathology in COPD; Smoking cessation and pharmacological treatment intervention. (2010) Timens, W Roscioni, S. S. Epac as a novel regulator of airway smooth muscle phenotype and function. Potential implications in asthma and COPD. (2010) Schmidt, M. and Meurs, H. Volbeda, F. The link of asthma outcome with AMP responsiveness and airway pathology. (2010) Postma, D. S., Timens, W., and ten Hacken, N. H. T. Dekkers, B. G. J. Major role of the extracellular matrix in airway smooth muscle phenotype plasticity. Implications for chronic asthma. (2010) Meurs, H. and Zaagsma, J. Journal articles Abello, N., Barroso, B., Kerstjens, H. A. M., Postma, D. S., Bischoff, R. Chemical labeling and enrichment of nitrotyrosine-containing peptides. Talanta 80(4): , Bergboer, J. G. M., Zeeuwen, P. L. J. M., Irvine, A. D., Weidinger, S., Giardina, E., Novelli, G., den Heijer, M., Rodriguez, E., Illig, T., Riveira-Munoz, E., Campbell, L. E., Tyson, J., Dannhauser, E. N., O'Regan, G. M., Galli, E., Klopp, N., Koppelman, G. H., Novak, N., Estivill, X., Mclean, W. H. I., Postma, D. S., Armour, J. A. L., Schalkwijk, J. Deletion of Late Cornified Envelope 3B and 3C Genes Is Not Associated with Atopic Dermatitis. Journal of Investigative Dermatology 130(8): , Birrell, M. A., van Oosterhout, A. J. M., Belvisi, M. G. Do the current house dust mite-driven models really mimic allergic asthma? European Respiratory Journal 36(5): , Blacquiere, M. J., Hylkema, M. N., Postma, D. S., Geerlings, M., Timens, W., Melgert, B. N. Airway Inflammation and Remodeling in Two Mouse Models of Asthma: Comparison of Males and Females. International Archives of Allergy and Immunology 153(2): , Blacquiere, M. J., Timens, W., van den Berg, A., Geerlings, M., Postma, D. S., Hylkema, M. N. Maternal smoking during pregnancy decreases Wnt signalling in neonatal mice. Thorax 65(6): , Bossenbroek, L., Kosse, N., ten Hacken, N., Gordijn, M., van der Hoeven, J., de Greef, M. VALIDATION OF THE DYNAPORT MINIMOD DURING SLEEP: A PILOT STUDY 3. Perceptual and Motor Skills 111(3): , Bottema, R. W. B., Nolte, I. M., Howard, T. D., Koppelman, G. H., Dubois, A. E. J., de Meer, G., Kerkhof, M., Bleecker, E. R., Meyers, D. A., Postma, D. S. Interleukin 13 and Interleukin 4 Receptoralpha Polymorphisms in Rhinitis and Asthma. International Archives of Allergy and Immunology 153(3): , Bottema, R. W. B., Kerkhof, M., Reijmerink, N. E., Koppelman, G. H., Thijs, C., Stelma, F. F., Smit, H. A., Brunekreef, B., van Schayck, C. P., Postma, D. S. X-chromosome Forkhead Box P3 polymorphisms associate with atopy in girls in three Dutch birth cohorts. Allergy 65(7): , Bottema, R. W. B., Postma, D. S., Reijmerink, N. E., Thijs, C., Stelma, F. F., Simit, H. A., van Schayck, C. P., Brunekreef, B., Koppelman, G. H., Kerkhof, M. Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE. European Respiratory Journal 35(1): 54-63, Bottema, R. W. B., Kerkhof, M., Reijmerink, N. E., Thijs, C., Smit, H. A., van Schayck, C. P., Brunekreef, B., van Oosterhout, A. J., Postma, D. S., Koppelman, G. H. Gene-gene interaction in regulatory T-cell function in atopy and asthma development in childhood. Journal of Allergy and Clinical Immunology 126(2): 338-U62, Bouzigon, E., Forabosco, P., Koppelman, G. H., Cookson, W. O. C. M., Dizier, M. H., Duffy, D. L., Evans, D. M., Ferreira, M. A. R., Kere, J., Laitinen, T., Malerba, G., Meyers, D. A., Moffatt, M., Martin, N. G., Ng, M. Y., Pignatti, P. F., Wjst, M., Kauffmann, F., Demenais, F., Lewis, C. M. Meta-analysis of 20 genome-wide linkage studies evidenced new regions linked to asthma and atopy. European Journal of Human Genetics 18(6): , Broekema, M., Volbeda, F., Timens, W., Dijkstra, A., Lee, N. A., Lee, J. J., Lodewijk, M. E., Postma, D. S., Hylkema, M. N., ten Hacken, N. H. T. Airway eosinophilia in remission and progression of asthma: 18

19 Accumulation with a fast decline of FEV1. Respiratory Medicine 104(9): , Brouwer, A. F. J., Brand, P. L. P., Roorda, R. J., Duiverman, E. J. Airway obstruction at time of symptoms prompting use of reliever therapy in children with asthma. Acta Paediatrica 99(6): , Brouwer, A. F. J., Visser, C. A. N., Duiverman, E. J., Roorda, R. J., Brand, P. L. P. Is Home Spirometry Useful in Diagnosing Asthma in Children With Nonspecific Respiratory Symptoms? Pediatric Pulmonology 45(4): , Budulac, S. E., Postma, D. S., Hiemstra, P. S., Kunz, L. I. Z., Siedlinski, M., Smit, H. A., Vonk, J. M., Rutgers, B., Timens, W., Boezen, H. M. Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD. Respiratory Research 11 AR 60 DI / : 60, Castro, M., Rubin, A. S., Laviolette, M., Fiterman, J., Lima, M. D., Shah, P. L., Fiss, E., Olivenstein, R., Thomson, N. C., Niven, R. M., Pavord, I. D., Simoff, M., Duhamel, D. R., McEvoy, C., Barbers, R., ten Hacken, N. H. T., Wechsler, M. E., Holmes, M., Phillips, M. J., Erzurum, S., Lunn, W., Israel, E., Jariour, N., Kraft, M., Shargill, N. S., Quiring, J., Berry, S. M., Cox, G. Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial. American Journal of Respiratory and Critical Care Medicine 181(2): , Caudri, D., Wijga, A. H., Hoekstra, M. O., Kerkhof, M., Koppelman, G. H., Brunekreef, B., Smit, H. A., de Jongste, J. C. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE. Thorax 65(9): , Cecchi, L., D'Amato, G., Ayres, J. G., Galan, C., Forastiere, F., Forsberg, B., Gerritsen, J., Nunes, C., Behrendt, H., Akdis, C., Dahl, R., Annesi-Maesano, I. Projections of the effects of climate change on allergic asthma: the contribution of aerobiology. Allergy 65(9): , Curjuric, I., Imboden, M., Schindler, C., Downs, S. H., Hersberger, M., Liu, S. L. J., Matyas, G., Russi, E. W., Schwartz, J., Thun, G. A., Postma, D. S., Rochat, T., Probst-Hensch, N. M. HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction. European Respiratory Journal 35(3): , de Groot, E. P., Duiverman, E. J., Brand, P. L. P. Comorbidities of asthma during childhood: possibly important, yet poorly studied. European Respiratory Journal 36(3): , de Jong, N. W., van Maaren, M. S., Vlieg-Boersta, B. J., Dubois, A. E. J., De Groot, H., van Wijk, R. G. Sensitization to lupine flour: is it clinically relevant? Clinical and Experimental Allergy 40(10): , de Vries, T. W., van den Berg, P. B., Duiverman, E. J., de Jong-van den Berg. Effect of a minimal pharmacy intervention on improvement of adherence to asthma guidelines. Archives of Disease in Childhood 95(4): , Dekkers, B. G. J., Bos, I. S. T., Halayko, A. J., Zaagsma, J., Meurs, H. The laminin beta 1-competing peptide YIGSR induces a hypercontractile, hypoproliferative airway smooth muscle phenotype in an animal model of allergic asthma. Respiratory Research 11 Dekkers, B. G. J., Bos, I. S. T., Gosens, R., Halayko, A. J., Zaagsma, J., Meurs, H. The Integrin-blocking Peptide RGDS Inhibits Airway Smooth Muscle Remodeling in a Guinea Pig Model of Allergic Asthma. American Journal of Respiratory and Critical Care Medicine 181(6): , den Bakker, M. A., Willemsen, S., Grunberg, K., Noorduijn, L. A., van Oosterhout, M. F. M., van Suylen, R. J., Timens, W., Vrugt, B., Wiersma-van Tilburg, A., Thunnissen, F. B. J. M. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability. Histopathology 56(3): , DunnGalvin, A., Cullinane, C., Daly, D. A., Flokstra-de Blok, B. M. J., Dubois, A. E. J., Hourihane, J. Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire - Parent Form in children 0-12 years following positive and negative food challenges. Clinical and Experimental Allergy 40(3): , Eisner, M. D. A. An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine (5): , Flokstra-de Blok, B. M. J., van der Velde, J. L., Vlieg-Boerstra, B. J., Oude Elberink, J. N. G., DunnGalvin, A., Hourihane, J. O., Duiverman, E. J., Dubois, A. E. J. Health-related quality of life of food allergic patients measured with generic and disease-specific questionnaires. Allergy 65(8): , Flokstra-de Blok, B. M. J., Dubois, A. E. J., Vlieg-Boerstra, B. J., Elberink, J. N. G. O., Raat, H., DunnGalvin, A., Hourihane, J. O., Duiverman, E. J. Health-related quality of life of food allergic patients: comparison with the general population and other diseases. Allergy 65(2): , Freathy, R. M., Mook-Kanamori, D. O., Sovio, U., Prokopenko, I., Timpson, N. J., Berry, D. J., Warrington, N. M., Widen, E., Hottenga, J. J., Kaakinen, M., Lange, L. A., Bradfield, J. P., Kerkhof, M., Marsh, J. A., Magi, R., Chen, C. M., Lyon, H. N., Kirin, M., Adair, L. S., Aulchenko, Y. S., Bennett, A. J., Borja, J. B., Bouatia- Naji, N., Charoen, P., Coin, L. J. M., Cousminer, D. L., de Geus, E. J. C., Deloukas, P., Elliott, P., Evans, D. M., Froguel, P., Glaser, B., Groves, C. J., Hartikainen, A. L., Hassanali, N., Hirschhorn, J. N., Hofman, A., Holly, J. M. P., Hypponen, E., Kanoni, S., Knight, B. A., Laitinen, J., Lindgren, C. M., McArdle, W. L., O'Reilly, P. F., Pennell, C. E., Postma, D. S., Pouta, A., Ramasamy, A., Rayner, N. 19

20 W., Ring, S. M., Rivadeneira, F., Shields, B. M., Strachan, D. P., Surakka, I., Taanila, A., Tiesler, C., Uitterlinden, A. G., van Duijn, C. M., Wijga, A. H., Willemsen, G., Zhang, H. T., Zhao, J. H., Wilson, J. F., Steegers, E. A. P., Hattersley, A. T., Eriksson, J. G., Peltonen, L., Mohlke, K. L., Grant, S. F. A., Hakonarson, H., Koppelman, G. H., Dedoussis, G. V., Heinrich, J., Gillman, M. W., Palmer, L. J., Frayling, T. M., Boomsma, D. I., Smith, G. D., Power, C., Jaddoe, V. W. V., Jarvelin, M. R., McCarthy, M. I. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nature Genetics 42(5): 430-U73, Gehring, U., Wijga, A. H., Brauer, M., Fischer, P., de Jongste, J. C., Kerkhof, M., Oldenwening, M., Smit, H. A., Brunekreef, B. Traffic-related Air Pollution and the Development of Asthma and Allergies during the First 8 Years of Life. American Journal of Respiratory and Critical Care Medicine 181(6): , Gosens, R., Baarsma, H. A., Heijink, I. H., Oenema, T. A., Halayko, A. J., Meurs, H., Schmidt, M. De novo synthesis of beta-catenin via H-Ras and MEK regulates airway smooth muscle growth. Faseb Journal 24(3): , Grandoch, M., Roscioni, S. S., Schmidt, M. The role of Epac proteins, novel camp mediators, in the regulation of immune, lung and neuronal function. British Journal of Pharmacology 159(2): , Halapi, E., Gudbjartsson, D. F., Jonsdottir, G. M., Bjornsdottir, U. S., Thorleifsson, G., Helgadottir, H., Williams, C., Koppelman, G. H., Heinzmann, A., Boezen, H. M., Jonasdottir, A., Blondal, T., Gudjonsson, S. A., Jonasdottir, A., Thorlacius, T., Henry, A. P., Altmueller, J., Krueger, M., Shin, H. D., Uh, S. T., Cheong, H. S., Jonsdottir, B., Ludviksson, B. R., Ludviksdottir, D., Gislason, D., Park, C. S., Deichmann, K., Thompson, P. J., Wjst, M., Hall, I. P., Postma, D. S., Gislason, T., Kong, A., Jonsdottir, I., Thorsteinsdottir, U., Stefansson, K. A sequence variant on 17q21 is associated with age at onset and severity of asthma. European Journal of Human Genetics 18(8): , Hartman, J. E., Boezen, H. M., de Greef, M. H. G., Bossenbroek, L., ten Hacken, N. H. T. Consequences of physical inactivity in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 4(6): , Heijink, I. H., Postma, D. S., Noordhoek, J. A., Broekema, M., Kapus, A. House Dust Mite-Promoted Epithelial-to-Mesenchymal Transition in Human Bronchial Epithelium. American Journal of Respiratory Cell and Molecular Biology 42(1): 69-79, Heijink, I. H., van Oosterhout, A., Kapus, A. Epidermal growth factor receptor signalling contributes to house dust miteinduced epithelial barrier dysfunction. European Respiratory Journal 36(5): , Heijink, I. H., Brandenburg, S. M., Noordhoek, J. A., Postma, D. S., Slebos, D. J., van Oosterhout, A. J. M. Characterisation of cell adhesion in airway epithelial cell types using electric cellsubstrate impedance sensing. European Respiratory Journal 35(4): , Herth, F. J., Eberhard, R., Gompelmann, D., Slebos, D. J., Ernst, A. Bronchoscopic lung volume reduction with a dedicated coil: A clinical pilot study. Therapeutic Advances in Respiratory Disease 4(4): , Huismans, H. K., Douma, W. R., Kerstjens, H. A. M., Renkema, T. E. J. Asthma in Patients Climbing to High and Extreme Altitudes in the Tibetan Everest Region. Journal of Asthma 47(6): , Jansen, S. R., Van Ziel, A. M., Baarsma, H. A., Gosens, R. beta- Catenin regulates airway smooth muscle contraction. American Journal of Physiology-Lung Cellular and Molecular Physiology 299(2): L204-L214, Kerkhof, M., Postma, D. S., Brunekreef, B., Reijmerink, N. E., Wijga, A. H., de Jongste, J. C., Gehring, U., Koppelman, G. H. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax 65(8): , Kerstjens, H. A., Bjermer, L., Eriksson, L., Dahlstrom, K., Vestbo, J. Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients. Respiratory Medicine 104(9): , Kerstjens, H. A. M., ten Hacken, N. H. T. Uplifting results of tiotropium in moderate COPD (GOLD stage 2). Evidence-Based Medicine 15(2): 44-45, Kocks, J. W. H., Kerstjens, H. A. M., Snijders, S. L., de Vos, B., Biermann, J. J., van Hengel, P., Strijbos, J. H., Bosveld, H. E. P., van der Molen, T. Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health and Quality of Life Outcomes 8 AR 135 DI / Koster, E. S., Wijga, A. H., Zuidgeest, M. G. P., Belitser, S. V., Raaijmakers, J. A. M., Koppelman, G. H., Postma, D. S., Brunekreef, B., de Jongste, J. C., Maitland-van der Zee, A. H. Patterns of asthma medication use: early asthma therapy initiation and asthma outcomes at age 8. Pharmacoepidemiology and Drug Safety 19(10): , Koster, E. S., Wijga, A. H., Raaijmakers, J. A. M., Koppelman, G. H., Postma, D. S., Kerkhof, M., Hoekstra, M. O., de Jongste, J. C., Smit, H. A., Brunekreef, B., Maitland-van der Zee, A. H. High agreement between parental reported inhaled corticosteroid use and pharmacy prescription data. Pharmacoepidemiology and Drug Safety 19(11): , Lambrechts, D., Buysschaert, I., Zanen, P., Coolen, J., Lays, N., Cuppens, H., Groen, H. J. M., Dewever, W., van Klaveren, R. J., Verschakelen, J., Wijmenga, C., Postma, D. S., Decramer, M., Janssens, W. The 15q24/25 Susceptibility Variant for Lung 20

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Annual Publication Report

Annual Publication Report Annual Publication Report 2008 TABLE OF CONTENTS 3 GRONINGEN INSTITUTE FOR KIDNEY DISEASES GIKD 8 CARDIOVASCULAR CENTER CVC 16 INSTITUTE FOR PHARMACOEPIDEMIOLOGY AND DRUG POLICY PEDP 20 GRONINGEN RESEARCH

More information

Drug Treatment in Type 2 Diabetes with Hypertension

Drug Treatment in Type 2 Diabetes with Hypertension Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Microalbuminuria: An increasingly recognized risk factor for CVD

Microalbuminuria: An increasingly recognized risk factor for CVD Microalbuminuria: An increasingly recognized risk factor for CVD Long known to be associated with kidney disease, the importance of protein in the urine is now becoming recognized as a sensitive, accessible

More information

Annual Publication Report

Annual Publication Report Annual Publication Report 2009 TABLE OF CONTENTS 2 GRONINGEN INSTITUTE FOR KIDNEY DISEASES GIKD 9 CARDIOVASCULAR CENTER CVC 19 GRONINGEN RESEARCH INSTITUTE FOR ASTHMA AND COPD GRIAC 24 CENTER FOR LIVER,

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Chronic Kidney Disease and Diabetes

Chronic Kidney Disease and Diabetes Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by

More information

PUBLICATIES NEFROLOGIE 2012

PUBLICATIES NEFROLOGIE 2012 PUBLICATIES NEFROLOGIE 2012 1. Abbasi A, Corpeleijn E, Peelen LM, Gansevoort RT, Jong PE de, Gans ROB, Rathmann W, Kowall B, Meisinger C, Hillege HL, Stolk RP, Navis GJ, Beulens JW, Bakker SJL. External

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

In many diabetes units, people with type

In many diabetes units, people with type Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for

More information

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.

More information

InDependent Diabetes Trust

InDependent Diabetes Trust InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

Diabetes and the Kidneys

Diabetes and the Kidneys Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary

More information

Prediction of Kidney Disease Progression in Patients with Diabetes

Prediction of Kidney Disease Progression in Patients with Diabetes Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting

More information

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

Diabetes and Your Kidneys

Diabetes and Your Kidneys American Kidney Fund reaching out giving hope improving lives Diabetes and Your Kidneys reaching out giving hope improving lives Diabetes: The #1 Cause of Kidney Failure Your doctor told you that you have

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

High Blood Pressure and Kidney Disease

High Blood Pressure and Kidney Disease High Blood Pressure and Kidney Disease National Kidney and Urologic Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH The kidneys play a key

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information

Guideline for Microalbuminuria Screening

Guideline for Microalbuminuria Screening East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Big Data for Population Health

Big Data for Population Health Big Data for Population Health Prof Martin Landray Nuffield Department of Population Health Deputy Director, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery University of Oxford

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use London, 25 September 2008 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE

More information

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와

More information

Understanding diabetes Do the recent trials help?

Understanding diabetes Do the recent trials help? Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.

More information

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4 High Blood Pressure and Chronic Kidney Disease For People With CKD Stages 1 4 National Kidney Foundation s Kidney Disease Outcomes Quality Initiative (NKF-KDOQI ) The National Kidney Foundation s Kidney

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency London, 19 July 2007 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR

More information

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Behçet s Disease and the Kidneys How are the kidneys affected by Behçet s disease? Kidney disease

More information

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI

More information

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME 1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome

More information

Can Common Blood Pressure Medications Cause Diabetes?

Can Common Blood Pressure Medications Cause Diabetes? Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES TITLE: Dual Antiplatelet Therapy and Enoxaparin or Unfractionated Heparin for patients with ST-elevation Myocardial Infarction: A Review of the Clinical Evidence DATE: 29 August 2012 CONTEXT AND POLICY

More information

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:

More information

Elective Project Report

Elective Project Report Elective Project Report I spent my elective at The Royal Free Hospital, London doing renal medicine. I decided to undertake my elective in renal medicine for two reasons: 1) I am very interested in this

More information

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Protocol. Cardiac Rehabilitation in the Outpatient Setting Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long

More information

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of

More information

The Canadian Association of Cardiac

The Canadian Association of Cardiac Reinventing Cardiac Rehabilitation Outside of acute care institutions, cardiovascular disease is a chronic, inflammatory process; the reduction or elimination of recurrent acute coronary syndromes is a

More information

25-hydroxyvitamin D: from bone and mineral to general health marker

25-hydroxyvitamin D: from bone and mineral to general health marker DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate

More information

High Blood Pressure and Chronic Kidney Disease

High Blood Pressure and Chronic Kidney Disease High Blood Pressure and Chronic Kidney Disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information

Dabigatran (Pradaxa) Guidelines

Dabigatran (Pradaxa) Guidelines Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, without

More information

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks 164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION. Van Crisco, MD, FACC, FSCAI First Coast

WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION. Van Crisco, MD, FACC, FSCAI First Coast WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION Van Crisco, MD, FACC, FSCAI First Coast Conflicts of Interest I have been a paid consultant and speaker for AstraZeneca, makers of

More information

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria )

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria ) 2006 17 99-105 2006 20-40% ( ESRD ) 30 299 mg ( ) ( 300 mgday ) DCCBs ) dihydropyridine calcium channel blockers ( non- DCCBs ( -blockers ( diuretics ) 10%) 0.8 ( 60 mlmin per 1.73 m 2 30 mlmin per 1.73

More information

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:

More information

Cardiovascular diseases. pathology

Cardiovascular diseases. pathology Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and

More information

Atherosclerosis of the aorta. Artur Evangelista

Atherosclerosis of the aorta. Artur Evangelista Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis

More information

Small artery tone under control of the endothelium

Small artery tone under control of the endothelium Small artery tone under control of the endothelium On the importance of EDHF and myogenic tone in organ (dys)function Simone K. Gschwend Publication of this thesis was supported by generous contributions

More information

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University

More information

Diagnostic and Therapeutic Procedures

Diagnostic and Therapeutic Procedures Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,

More information

How To Know If Low Protein Diet Is Beneficial For Kidney Health

How To Know If Low Protein Diet Is Beneficial For Kidney Health Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy

More information

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic

More information

R EFERENCES. Summary and conclusions

R EFERENCES. Summary and conclusions R EFERENCES Summary and conclusions 129 S UMMARY AND CONCLUSIONS SUMMARY AND GENERAL DISCUSSION 130 Constant vasodilatation, inhibition of platelet and monocyte adhesion, and local thrombolysis are the

More information

Is Insulin Effecting Your Weight Loss and Your Health?

Is Insulin Effecting Your Weight Loss and Your Health? Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults

More information

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary

More information

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Multiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden

Multiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden Multiple comorbidities: additive and predictive of cardiovascular risk Peter M. Nilsson Lund University University Hospital Malmö, Sweden Clinical outcomes: major complications of CVD Heart Attack/ACS

More information

Identifying and treating long-term kidney problems (chronic kidney disease)

Identifying and treating long-term kidney problems (chronic kidney disease) Understanding NICE guidance Information for people who use NHS services Identifying and treating long-term kidney problems (chronic kidney disease) NICE clinical guidelines advise the NHS on caring for

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Low Molecular Weight Heparin All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Starting Point Low Molecular Weight Heparin (LMWH): Inhibits factor Xa and factor IIa (thrombin) Small

More information

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options?

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? Patient decision aid Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? http://guidance.nice.org.uk/cg180/patientdecisionaid/pdf/english Published: June 2014 About

More information

Introduction. Pathogenesis of type 2 diabetes

Introduction. Pathogenesis of type 2 diabetes Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic

More information

Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants

Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Relevant Licensed Indications

More information

Position Statement Diabetic Nephropathy American Diabetes Association

Position Statement Diabetic Nephropathy American Diabetes Association Information obtained from the American Diabetes Association 2002 by the American Diabetes Association, Inc. Publication Date January 2002 in Diabetes Care 25:S85-S89, 2002 Edited by the Nephrology Department,

More information

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have

More information